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ABSTRACT 
Reliability and Validity of the Progress Questionnaire: 
An Adaptation of the Outcome Questionnaire 
Jason E. Chapman 




Patient- focused research is a methodology that involves the regular measurement 
of patient progress in treatment and the provision of feedback to clinicians to allow 
modification of interventions to maximize outcomes. A critical component of patient-
focused research endeavors is the availability of psychometrically sound assessment 
questionnaires, and one such measure is the Outcome Questionnaire (OQ-45.2). This 
investigation was comprised of three stud ies. Study 1 examined the factor structure and 
internal consistency of the Progress Questionnaire (PQ), an adaptation of the OQ-45.2, in 
278 patients seeking psychotherapy and/or medication management services at a large, 
urban outpatient mental health clinic. Study 2 examined the factor structure and internal 
consistency of the OQ-45.2 in a sample of 450 patients receiving outpatient 
psychotherapy in numerous locations. Study 3 examined the temporal stability of the 
factor structure of the OQ-45.2. 
The PQ and OQ-45.2 were found to possess desirable estimates of internal 
consistency, similar to those previously reported for the OQ-45.2. The theoretically 
derived three factor structure of the OQ-45.2 was submitted to Confirmatory Factor 
Analysis (CFA) and found to be implausible for the PQ and the OQ-45.2. The studies 
next turned to exploratory procedures so as to investigate the empirical factor structures 
of the questionnaires. Results of a Principle Components Analysis (PCA) with Promax 
rotation revealed that the PQ was comprised of ten correlated factors accounting for 60% 
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of the observed variance. Similarly, the OQ-45.2 was comprised of nine correlated 
factors accounting for 62% of the observed variance. The sample size in Study 2 
permitted validation of this factor structure through CFA. The nine factor model provided 
significantly improved fit to the three factor model previously tested but was still 
implausible. Study 3 found that the nine factor structure obtained with baseline data was 
not stable when imposed on a sample of data from the fourth assessment. The results 
suggest that the PQ is statistically less effective than the OQ-45.2, and further use of the 
modified version is not recommended. Possible explanations for the poor fit of the factor 
structures are offered, and guidelines are provided for future psychometric studies 
examining the OQ-45.2.  
 
 









 Numerous questions pertaining to the delivery and outcomes of psychotherapy 
have long faced researchers and practitioners within the field of clinical psychology. 
Examples range from those concerning the benefits of a particular treatment approach for 
patients, to those concerning which of several treatment alternatives is maximally 
beneficial to patients with specific diagnoses, to questions of the “active ingredient” of a 
given approach, to more recent, practical issues such as the authorization of treatment 
sessions by managed care organizations. Research designs that aim to answer inquiries 
such as these are both influenced and determined by the unique features, qualities, and 
considerations associated with the different methodological approaches and the settings 
in which they occur. 
 Psychotherapy outcome studies have traditionally been classified as falling 
between two ends of a continuum, one end occupied by efficacy research methodologies 
and the other by effectiveness research methodologies (Kazdin, 1999). While the 
preceding are accompanied by specific limitations, such as the lack of generalizability 
associated with efficacy research, each approach offers unique advantages that allow for 
the investigation of therapy outcomes. The use of random assignment, control groups, 
treatment manuals, and therapist training typify the domain of efficacy research 
(Dornelas, Correll, Lothstein, Wilber, & Goethe, 1996). These investigations are 
characterized by an emphasis on the limitation of threats to internal validity, thereby 
allowing the determination of causal inferences (Kazdin). Because this approach enjoys a 
high degree of internal validity, randomized clinical trials are often considered the “gold 
standard” of research methodologies. 
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 Occupying the opposite end of this traditional spectrum of research 
methodologies is effectiveness research. This approach attempts to capitalize on the 
limitations of efficacy research, namely lack of external validity. Thus, effectiveness 
research is characterized by a greater degree of external validity (Goldfried & Wolfe, 
1998). Rather than focus on control of numerous threats to internal validity, effectiveness 
research methodologies focus to a greater extent on the generalizability of findings 
through investigation of the clinical setting itself, as it occurs outside of the controlled 
laboratory (Kazdin, 1999). Whereas this approach relies on the collection and post-hoc 
analysis of data, a newer research methodology, patient- focused research, takes the 
notion of generalizability a step further through its simultaneous collection and clinical 
use of the data. 
1.1. Patient-Focused Research 
According to Lyons, Howard, O’Mahoney, and Lish (1997), while a great deal is 
currently known about the ability of various therapies to work under controlled 
circumstances, increasing recent concerns focus more directly on the nature of the 
relationships among consumers, treatments, and providers. In other words, provided 
empirically derived knowledge of treatments’ abilities to work under ideal conditions, 
research must then aim to answer questions about treatments as they are routinely 
delivered in actual clinical practice. In response, a brand of outcome research receiving 
increased attention of late, and offering benefits unique from the efficacy and 
effectiveness research methodologies described above, has emerged, one in which the 
global aim is the improvement of psychotherapy outcomes through increased focus on 
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and attention to the treatment responses of individual consumers rather than groups of 
consumers (Lambert, 2001).  
While efficacy and effectiveness research studies answer questions about whether 
treatments are able to work or do work in applied settings, respectively, the patient 
focused research approach is concerned with whether a given treatment is working for the 
individual consumer (Howard, Moras, Brill, Martinovichc, & Lutz, 1996). Among the 
remaining attributes that serve to demarcate patient- focused research methodologies from 
the traditional methodologies are: the use of statistical analyses, such as hierarchical 
linear modeling, specifically tailored to its goals and sensitive to individual consumer 
change; emphasis on cost-effectiveness; aims of quality improvement through 
modification or adjustment of treatments delivered; increased generalizability of findings; 
and the provision of feedback to the practitioner (Lambert, 2001). 
 As may be evident from the characteristics, focus, and aims just discussed with 
respect to the patient- focused research methodology, a common arena for the conduction 
of this type of inquiry and investigation is the managed care setting. Several reasons exist 
for this, including: (a) the rapid growth of managed care and its associated focus on 
service effectiveness, (b) the growth of consumer-based groups concerned with the 
quality of services provided, (c) information technology and the ability to efficiently 
utilize and maintain massive electronic databases, and (d) a new focus based in the 
application of outcome data for the purpose of refinement of treatments delivered (Lyons, 
et al., 1997). Likewise, Pallak and Cummings (1994) cite increasing costs associated with 
service delivery and the availability of applicable assessment instruments, with respect to 
content and practicality, in managed care settings as additional reasons for the increase in 
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outcomes assessment observed under managed care. An additional factor in the 
relationship between managed care and patient focused research is that the position and 
role of managed care organizations requires decision making with reference to a number 
of factors associated with therapy. Lambert, Huefner, and Nace (1997) state that such 
organizations commonly make treatment decisions about the types of treatments to cover, 
the number of sessions to authorize, and which settings and levels of care to provide. 
The conduction of patient- focused research within the managed care setting offers 
a number of benefits, among the primary of which is access to and utilization of large and 
comprehensive sets of data about each consumer (Lambert et al., 1997). That is, managed 
care companies possess sizable, electronic databases containing an extensive amount of 
routinely gathered information for each consumer. Thus, the authors argue, patient-
focused research within the managed care setting bypasses one of the major obstacles of 
traditional psychotherapy outcome research, sample size, as samples entering into the 
thousands are frequently observed. 
 Lambert et al. (2001) describe the development of the patient- focused research 
methodology as largely the result of economic and practical considerations as well as 
limitations in traditional outcomes research. Accordingly, two standards for which 
patient-focused research must strive are cost-effectiveness and increased external validity 
(Lambert et al.). Though acknowledging the specific, significant benefits of 
methodological considerations such as multimodal assessment, the settings in which 
patient-focused research frequently occur cannot endure the time, financial, and other 
resource burdens required by such strategies. Lyons et al. (1997) argue that if these 
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limitations are ignored, the consequence is a negative experience for both consumers and 
providers, resulting in failed research endeavors. 
While possessing numerous benefits, given the above constraints, the “gold 
standard” efficacy research methodology is viewed as impractical and counterproductive 
in many settings because of its associated resource demands (Lambert et al., 2001). 
Similarly, effectiveness research investigations, while increasingly generalizable and 
more consistent with the patient- focused research methodology, are constrained by their 
focus on group level data and delayed dissemination of research findings. That is, 
practitioners receive details regarding the effects of treatment subsequent to study 
completion, thereby preventing alteration and modification of the approach for the 
purpose of improving outcomes. Additionally, such details are available only at group 
level, with details specific to individual consumers remaining unknown. 
1.2. Outcomes Assessment and the Outcome Questionnaire  
In order to achieve the aims discussed above, an effective and efficient means of 
tracking consumer changes must be developed; however, this raises additional issues: 
selection of an instrument(s) to use, methods of evaluating the measures, determining 
measures appropriate for a given setting, and selecting instruments in light of the 
practical constraints of the setting. According to Lambert et al. (2001) outcome 
assessment instruments utilized for the purposes of tracking functional outcomes across 
disorders must be brief, easily administered and scored, suitable across diagnoses, 
psychometrically sound, sensitive to change across time, and inexpensive. 
One such instrument, developed specifically around these aims (Lambert & Finch, 
1999), is the Outcome Questionnaire (OQ-45.2; Lambert et al., 1996). A substantial 
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degree of evidence exists supporting the ability of the OQ-45.2 to meet the criteria listed 
above (e.g., Lambert et al.). The OQ-45.2 is a measure of the consumer’s level of 
symptoms of psychological distress, interpersonal functioning, and functioning in work, 
school, or primary role pursuits. The measure consists of 45 items ; requires 
approximately five to seven minutes for completion, so as to be compatible with routine 
clinical practice; is written at a 6th grade reading level; contains items that are applicable 
across disorders and likely to be endorsed across consumers; requires minimal oversight 
by the administrator; requires approximately three to five minutes to score; costs a 
nominal charge per administration; and possesses sound psychometric characteristics 
(e.g., Lambert, 1999).  
The OQ-45.2 was designed to meet the needs of and provide a valuable resource 
for two primary groups: managed care organizations and individual practitioners (Wells, 
Burlingame, Lambert, Hoag, & Hope, 1996). Potential applications of the OQ-45.2 for 
managed care organizations, described by Wells et al., include: tracking the quality of 
services delivered, informing decisions regarding treatment allocation, gathering data on 
the effectiveness of treatments, provider profiling, and with sufficiently large samples, 
predicting treatment duration, authorizing sessions, and evaluating novel therapeutic 
interventions. With respect to the needs of the independent practitioner, potential uses 
include: determining consumer progress, making relevant decisions regarding the course 
of treatment, providing a baseline measure of pathology, monitoring changes occurring 
throughout treatment, and assessing the effectiveness of various treatment interventions. 
 The OQ-45.2 assesses three theoretically derived domains: (a) Symptom Distress 
(SD), (b) Interpersonal Relations (IR), and (c) Social Role (SR, Lambert & Finch, 1999). 
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The first subscale, SD, is composed of symptoms representative of the most commonly 
occurring diagnoses, depression and anxiety. The second subscale, IR, is a measure of 
interpersonal functioning, including both satisfaction and problem-related items about the 
consumer’s relationships with others. The authors argue that these items were included as 
a result of the commonly observed relationship, as evidenced in clinical practice, between 
interpersonal problems and symptoms of distress. The final subscale, SR, is comprised of 
items relating to the consumer’s level of satisfaction with and functioning within his/her 
primary role area. The items in the SR subscale were selected because, according to the 
authors, role functioning is commonly impacted by psychological distress and is therefore 
an important domain in outcome assessment. 
 The originators of the OQ-45.2 have published several studies detailing findings 
of the instrument’s psychometric properties (e.g., Lambert et al., 1996). Below is a 
summary of these findings, followed by a discussion of the associated limitations and 
questions that remain about the operating characteristics of the OQ-45.2. 
1.3. Psychometric Properties of the OQ-45.2 
Estimates of the test-retest reliability and internal consistency of the OQ-45.2 are 
based on data collected from two samples: undergraduate students (N=157) and 
individuals receiving services through employee assistance programs (EAPs; N=290; 
Lambert, Burlingame, et al., 1996). Internal consistency estimates were calculated 
separately for the undergraduate and EAP samples. With respect to the undergraduate 
sample, coefficient alpha for the OQ-45.2 total score was .93, and was .92, .74, and .70 
for the SD, IR, and SR subscales, respectively. With respect to the EAP sample, 
  8 
 
coefficient alpha for the OQ-45.2 total score was .93, and was .91, .74, and .71 for the 
SD, IR, SR subscales, respectively. 
Test-retest reliability estimates were calculated with data collected from only the 
undergraduate sample with a three week interval between the two administrations. The 
overall correlation coefficient was .84, with coefficients for the SD, IR, and SR subscales 
of .78, .80, and .82, respectively. 
Several studies have been conducted for the purposes of estimating the validity 
properties of the OQ-45.2; the majority of which are subsumed under the category of 
construct validity investigations. Lambert, Burlingame et al. (1996) used the 
undergraduate sample described above to assess the convergent validity of the OQ-45.2. 
The OQ total score and subscale scores were correlated with a number of commonly 
employed measures of anxiety, depression, social functioning, and interpersonal 
relationship functioning, so as to assess the convergent validity of the three theoretical 
domains of the OQ-45.2. The measures used for comparison were the Symptom 
Checklist-90-Revised (SCL-90-R), Beck Depression Inventory (BDI), State-Trait 
Anxiety Inventory (STAI), Zung Self-Rating Depression Scale (ZSDS), Zung Self-Rating 
Anxiety Scale (ZSAS), Taylor Manifest Anxiety Scale (TMAS), Inventory of 
Interpersonal Problems (IIP), and the Social Adjustment Scale (SAS-SR). Results 
indicated that the OQ-45.2 correlated highly with the convergent measures. Correlation 
coefficients calculated between the OQ-45.2 total score and each of the measures ranged 
from .60 to .88. Among the subscales, the highest correlations were observed between the 
SD scale and the measures, with correlations ranging from .50 to .89. 
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Additional support for the convergent validity of the OQ-45.2 was found by 
Umphress et al. (1997). Results revealed moderate to high validity coefficients between 
the OQ-45.2 total score and the measures of anxiety, depression, social functioning, and 
interpersonal relationship functioning, with which it was correlated, ranging from .71 to 
.84 in the community treatment center sample. Of the three subscales, the SD correlated 
most highly with the convergent measures, with correlations ranging from .65 to .84, 
while the remaining subscales produced significant but smaller correlation coefficients. 
Thus, there is evidence supporting the convergent validity of the OQ-45.2 with 
commonly employed, theoretically related measures; however, the question remains as to 
whether the OQ-45.2 empirically is comprised of three subscales or whether it is a global 
measure of symptom distress.  
Lambert, Burlingame, et al. (1996), to assess the construct validity of the OQ-45.2 
examined the ability of the OQ-45.2 to demonstrate sensitivity to changes occurring in a 
consumer sample over time. The authors used a sample of 40 consumers receiving 
outpatient treatment. Pretest scores were compared to scores after seven sessions of 
therapy. Results of a repeated measures t test indicated that the two scores were 
significantly different in the direction of improvement, suggesting that the OQ-45.2 was 
sensitive to the types of changes resulting from therapeutic intervention. In addition, 
Vermeersch, Lambert, and Burlingame (2000) used hierarchical linear modeling to 
provide an additional investigation of the sensitivity of the OQ-45.2 to changes. Results 
were based on data collected from 1,176 consumers receiving therapy at outpatient 
mental health centers and a sample of 284 undergraduates who were not receiving 
treatment. All participants completed the OQ-45.2 on three occasions. Results indicated 
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that the OQ-45.2 is largely sensitive to change based on the overall score as well as the 
three subscale scores. 
In another article, Umphress et al. (1997) report additional findings in support of 
the construct validity of the OQ-45.2. This study utilized a sample of community normals 
(N=210), consumers from a college counseling center (N=53), a community health clinic 
(N=106), and an inpatient psychiatric unit (N=24). An ANOVA was conducted to 
determine the ability of the OQ-45.2 to correctly discriminate groups as ranked from least 
to most severe. Results indicated that means of the patient and community groups 
differed in the expected directions, from inpatient (highest) to normals (lowest).  
The authors reported additional support for the construct validity of the OQ-45.2 
from the community clinic sample by investigating whether there were significant 
differences in the OQ-45.2 score between individuals with Axis I diagnoses and those 
with V-Code diagnoses. An independent t test supported this hypothesis for the OQ-45.2 
total score and two of the three subscales, indicating that those with Axis I diagnoses had 
significantly higher OQ-45.2 scores than those with V-Code diagnoses. 
Finally, Umphress et al. (1997) found that, using the OQ-45.2 total score, they 
were able to correctly identify 85% of a clinical sample and correctly classify 74% of a 
normal sample, thus reflecting the sensitivity and specificity, respectively, of the OQ-
45.2 when employing its cutoff scores. 
Results of a confirmatory factor analysis (CFA) used to investigate the 
theoretically derived three factor structure described above were less clear (Mueller, 
Lambert, & Burlingame, 1998). Three models were tested: (a) the three factor solution; 
(b) a two factor solution consisting of an internal factor, items related to individual 
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symptom distress, and an external factor, items relating to external events (e.g., 
relations); and (c) a one factor solution, representing a factor of general symptom 
distress. While, of the three models, the best fit was achieved by the three factor solution, 
none of the models demonstrated good fit (Mueller et al., 1998). The authors state that the 
results “failed to support” the theoretically derived multifactor solution (p. 260). 
Thus, as can be seen from that presented above, the OQ-45.2 enjoys a significant 
amount of empirical support for its psychometric properties. However, this body of 
research and the associated findings are not without limitations. Mueller et al. (1998) call 
for additional empirical investigations of the factor structure of the OQ-45.2 and suggest 
that such studies may necessarily involve modification of the measure. One possible 
confound in the study presented above, cited by the authors, involves the potential impact 
of the sample characteristics on their failure to strongly support the three factor structure. 
The sample was not based totally in clinical populations; rather, it included both 
community normals (10%) and undergraduate normals (28%). In addition, the clinical 
portion of the sample contained a large percentage (nearly 50%) from an EAP, a less 
clinically diverse population. In reality, the community mental health center sample 
comprised only a small percentage of the total sample (15%), and Mueller et al. 
acknowledge the potential benefits of limiting future CFAs to an all clinical sample. 
Finally, the authors recognize the negative impact of their large sample size (N=1,085) on 
the results of the CFA and the resulting inflation in Type II error rate. 
Previous research has found a significant degree of correspondence among the 
three subscales of the OQ-45.2, providing empirical evidence that it is a global measure 
of symptom distress (Mueller et al., 1998). However, the results of the study described 
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above contrast this. Recall that, of the three factor solutions tested, the three factor 
solution was found to posses the best fit. Thus, contradictory evidence exists regarding 
the factor structure of the OQ-45.2 from several sources. While some of the existing 
evidence points to the OQ-45.2 as best characterized as a one factor measure of distress, 
other empirical evidence exists in support of the three factor solution. As a result, the 
authors call for further investigation and allow for the possibility of item modification so 
as to clarify its domains. 
Inspection of the correlations among the subscales of the OQ-45.2, the three 
theoretically derived factors, revealed that a significant degree of interrelationship exists 
among the three factors (Lambert, 1999). This suggests that, rather than being comprised 
of three distinct factors, the OQ-45.2 may be better characterized as a global measure of 
symptom distress (Umphress et al., 1997). 
Additionally, each of the studies presented above was conducted by researchers 
directly involved in the development of the OQ-45.2. That is, none of the empirical 
findings of the operating characteristics of the OQ-45.2 have been investigated by 
researchers independent of those directly involved with the measure’s development. 
The sample characteristics of each of the previously described studies are 
questionable with respect to generalizability. For instance, approximately 90% of each 
sample was Caucasian. This characteristic under-represents various ethnic groups 
routinely observed in clinical practice in many geographical locations. Likewise, the 
sample for a study by Nebeker, Lambert, and Huefner (1995) on ethnic differences on the 
OQ-45.2 was comprised of 86% Caucasians. While results were favorable, finding no 
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ethnic differences, a more diversified sample is desirable, especially when investigating 
ethnic differences.  
Also related to generalizability, a number of the reliability and validity estimates 
observed above were based on data collected from college undergraduates and/or 
community normals. The reliability estimates of the OQ-45.2 appear strong according to 
standard guidelines. Nunnally and Bernstein (1994) suggest that, when scores are used to 
make decisions about individuals, rather than simply detecting group differences, the 
guidelines for acceptability of reliability estimates should be increased to .90. Though 
some estimates were based on clinical samples, those based on undergraduate and/or 
normal samples may differ in meaningful ways from those observed in actual clinical 
practice, the setting for which the OQ-45.2 was designed. Thus, many of the conclusions 
drawn by the authors regarding the desirable psychometric characteristics of the OQ-45.2 
are based largely on samples with which the measure was not designed or intended for 
use and populations which seriously confound conclusions about the measure’s reliability 
and validity properties. 
Finally, despite the existence of many studies with large sample sizes conducted 
on the OQ-45.2, there are no reports of an exploratory factor analysis being conducted, 
and only one confirmatory factor analysis has been reported. Given the questionable 
results surrounding the factor structure of the OQ-45.2, as described above, and the 
numerous large-sample studies conducted, failure to conduct additional analyses of the 
instrument’s factor structure is surprising. According to Nunnally and Bernstein (1994), 
when empirical evidence fails to support a theoretically derived factor structure, either 
the relationship was not found, it does not exist, or it exists in a different direction. Thus, 
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a number of important questions remain regarding the factor structure of the OQ-45.2, 
and while enjoying empirical support for its operating characteristics, the measure is in 
need of further investigations and possesses significant shortcomings. 
1.4. Modification & Validation of Assessment Instruments 
 Modification of existing assessment instruments and outcome measures is 
common practice; this frequently occurs to render a measure more closely suited to the 
specific purposes and environment for which it is intended and such that it answers the 
specific questions it is intended to answer (Kazdin, 1993). According to Kazdin (1999), 
such adaptations, when relevant to a particular setting, are justifiable insofar as the 
changes are necessary. The benefit of this practice is that when an existing measure is 
altered, it is not as if one is beginning anew, knowing nothing of the properties of the 
instrument.  
The OQ-45.2 was selected as a means of conducting patient focused research, 
generally, and monitoring treatment outcomes, specifically. In the current setting the OQ-
45.2 has been modified such that it now contains additional items considered to be either 
missing or underrepresented in the original version. This new instrument has been named 
the Progress Questionnaire (PQ).The present study is of the type just described; that is, it 
is a psychometric investigation of an adaptation of the OQ-45.2, the PQ, and will occur in 
a managed care environment.  
The fundamental rationale for proposing this study is twofold: (a) The original 
OQ-45.2 items are being used in a new environment, thus, as will be shown, necessitating 
re-evaluation of its psychometric characteristics, and (b) The questionnaire has been 
altered through the addition of fifteen items, thereby rendering a new instrument. With 
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respect to the former, the relative degree of validity possessed by a given measure is 
influenced by a number of factors specific to the environment in which it is employed 
(Haynes, Nelson, & Blaine, 1999; Nunnally & Bernstein, 1994). Variables such as 
assessment strategies, target population characteristics, validity judgments, methods of 
validation, etc. fluctuate from setting to setting and therefore influence estimates of 
reliability and validity. This argument is echoed by many authors, for instance, Anastasi 
(1986) argues that because the psychometric characteristics of an instrument fluctuate 
with respect to both time and setting and are not simply achieved and retained, they must 
be assessed repeatedly. Likewise, Lyons et al. (1997) state that estimation of a measure’s 
reliability should occur by whomever is conducting research that utilizes the measure. 
Given the numerous arguments above, the need for psychometric analysis of the PQ 
operating in a new environment is necessary. 
As stated previously, the second reason for the proposed investigation stems from 
the modification of the original OQ-45.2 through the addition of new questions, rendering 
a psychometrically new instrument. As a result, evaluation and documentation of the 
reliability and validity estimates of the new measure is necessary, and there are numerous 
reasons for the importance of this. According to Kazdin (1999), though some data 
reflecting the measure’s reliability and validity may exist, the new instrument is different, 
subsequently requiring further demonstration of its psychometric properties. Because 
there are a number of significant potential uses for outcome data gathered in a managed 
care environment, ranging from the provision of provider feedback to decision making 
about session authorizations, psychometric analysis of the new instrument must occur to 
demonstrate the legitimacy of its use and confidence in decisions resulting from its use. 
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Outcome measurement is a prerequisite for decision making, and as will be 
shown, there are additional reasons for investigating an instrument’s psychometric 
characteristics. Indeed, Dornelas et al. (1996) argue that psychometric properties should 
be among the primary considerations in the selection of outcome instruments. There 
exists a substantial literature referencing as a required step the examination of the 
operating characteristics of measures used for the purpose of outcome monitoring (e.g., 
Berman et al., 1998; & Burlingame et al., 1995). Because the results of such tests serve to 
inform decisions and consequently affect individuals, the reliability and validity 
characteristics of the measurements must be considered. Likewise, the Ethics Code of the 
American Psychological Association addresses test construction and the importance of 
appropriate procedures for developing and using testing (APA, 1992). Sonnanburg (1996) 
argues that, despite the purported purpose, observations resulting from any test are 
unusable and of limited significance unless first critically examined. Burlingame et al. 
(1995), echoing concern over the use of data from unvalidated measures, state that, 
“…any decision using the measure is highly suspect” (p. 227). Similarly, lacking test 
validation efforts, little confidence can be place in the meaning and interpretation of test 
results (Reckase, 1996). Finally, while Berman et al. (1998) cite the need for the 
development of sound symptom-related measures, new methodologies for data collection, 
and the use of large samples Burlingame et al. (1995) suggest that the psychometric 
characteristics of instruments used for data collection impose an upper limit on the value 
of any gathered data. Thus, there are numerous arguments for investigations such as this, 
and following is a discussion of recommendations for performing such investigations. 
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1.5. Recommendations for Estimating Reliability & Validity 
 Numerous recommendations exist in the literature as to which types of reliability 
and validity are to be assessed when conducting psychometric evaluations of assessment 
instruments. Commonly agreed upon is that this important process is often neglected 
(e.g., Smith & McCarthy, 1995). Though variable at times, recommendations offered 
were largely consistent in scope. Following is a brief discussion of the types of reliability 
and validity most frequently evaluated and reported in psychometric investigations such 
as that presently proposed. These guidelines provide the foundation for the statistical 
methods described later. 
 According to Smith and McCarthy (1995), the proper refinement of outcome 
measures is a two phase process. The first phase of this process involves the 
identification of the instrument’s factor structure and estimation of its internal 
consistency. Subsequent to this, the second phase entails demonstration of the degree of 
relationship between the instrument and other important variables. The present study 
focuses on the former phase, though each phase is briefly reviewed below. 
 With respect to evaluation of an instrument’s reliability, internal consistency is 
defined as the degree to which the items comprising a measure covary in one individual 
taking the test one time (Strube, 2000). While internal consistency refers to the degree to 
which items comprising a test are interrelated, it does not indicate that the test is 
necessarily unidimensional (Schmitt, 1996). Determination of the reliability of measures 
is important because it allows for generalization of the results obtained by the measure, 
and without reliability, validity cannot be established (Nunnally & Bernstein, 1994). 
Likewise, without establishing the internal consistency of a measure, the relative degree 
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of error variance of the measure is unknown, thus making uncertain the degree to which 
an individual’s score represents a true index of the measure (Smith & McCarthy, 1995). 
 Nunnally and Bernstein (1994) state emphatically the importance of internal 
consistency estimate calculation for new measures or new uses of existing measures, “It 
[Chronbach’s coefficient alpha] is so pregnant with meaning that it should routinely be 
applied to all new tests,” and “…there is no excuse for not computing it [Chronbach’s 
coefficient alpha] for any new measure” (p. 234; emphasis original). 
 Temporal stability, also known as test-retest reliability, represents the correlation 
between the scores of the same test administered to the same individual with a delay 
between administrations (Kazdin, 1998). It is important to assess the degree to which 
scores on the measure are consistent with a delay between administrations, as it provides 
information regarding the extent of natural fluctuation in scores that is expected over time 
(Sonnanburg, 1996). This provides an estimate of the stability of the domains assessed by 
a measure (Groth-Marnat, 1990), though it should be noted that with state-like measures 
(i.e., symptom focused measures), temporal stability may be lacking in information as a 
result of naturally occurring fluctuation in scores (Nunnally & Bernstein, 1994). 
With respect to the components of validity, while content validity is commonly 
recognized as one of the principle types of validity (e.g., Nunally & Bernstein, 1994; 
Smith & McCarthy, 1995), it will not be specifically addressed in the present study for 
three primary reasons. First, because this investigator was not directly involved in the 
item selection process, it is inappropriate to comment on the associated decision making 
process and theoretical rationale without an empirically based approach of doing so. 
Second, this process, as it relates to the original items of the OQ-45.2 has been described 
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elsewhere (e.g., Wells et al., 1996). Finally, discussion is deferred based on the 
recommendations of Nunnally and Bernstein (1994) who suggest that the description of a 
measure’s content validity is limited in its empirical backing and is largely dependent 
upon argument and theoretical agreement. Thus, the following is limited to discussion of 
construct validity. 
 The second major type of validity is construct validity. Construct validity is 
defined as whether an instrument, in practice, measures that which it purports to measure 
(Bryant, 2000). Encompassed by the category of construct validation are two additional 
types of validity: convergent and discriminant (Nunnally & Bernstein, 1994). 
Respectively, convergent and discriminant validity represent the correlation between the 
measure of interest and another theoretically similar measure with which it is expected to 
correlate highly and the correlation between the measure of interest and another 
theoretically dissimilar measure with which it is not expected to correlate (Kazdin, 1998). 
Assessment of convergent and discriminant validity provides significant detail about the 
characteristics of the measure of interest, that it relates in expected ways to similar 
measures and to measures to which it should not relate. Nunnally and Bernstein (1994) 
echo this sentiment, recommending empirical investigation of both convergent and 
discriminant validity, and Chronbach (1990) argues that estimation of an instrument’s 
convergent and discriminant validity properties is one of the key steps in the process of 
establishing a measure’s construct validity. 
1.6. Contribution 
The current study involves a psychometric analysis of the OQ-45.2 adaptation, 
estimating various components of its reliability and validity properties. Before turning to 
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a discussion of the specific methodological considerations in the current study, the 
potential contribution of that which follows will be addressed. As discussed thus far, 
investigations such as this are crucial to the proper development and ethical application 
of new assessment instruments. However, such studies provide more extensive benefits 
than the simple provision of empirically based evidence for the measure’s psychometric 
characteristics.  
With the rise of managed care’s requirement of provider accountability, outcome 
measures such as the OQ-45.2 and PQ will find increasingly widespread applications and 
play an important role in decision making and quality improvement (Johnson & Shaha, 
1996). This is evidenced, in the current setting, by the fact that additional managed care 
providers will begin implementation of the PQ in the future for purposes similar to those 
described herein (M. Hart, personal communication, July 5, 2001). Along similar lines, 
Clark and Watson (1995) argue that because of the real-world applications of many 
outcome measures, clear demonstration of the operating characteristics of such 
instruments is increasingly being required. Thus, such an investigation holds the potential 
to further establish a potentially widely applicable assessment instrument that is largely 
compatible with current trends in managed care and patient focused research. 
The current study is also in response to Mueller et al. (1998) who called for 
additional psychometric investigations into the factor structure of the OQ-45.2. Firstly, 
following the recommendation of Reckase (1996), this study will provide a complete 
review of an assessment instrument by individuals other than those who created the 
measure. While a considerable amount of psychometric data exists in support of the OQ-
45.2, the majority, if not all, of it descends directly from researchers involved with its 
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development. Secondly, this study will attempt to correct for the previously cited 
shortcomings of existing research on the OQ-45.2, namely, the inclusion of a large 
percentage of normal participants for whom the test is not intended. In addition, it will 
utilize an appropriate sample size for factor analytical procedures. 
1.7. Goals & Hypotheses 
 In this investigation, there were four primary questions of interest which were 
addressed in three distinct studies. In Study 1 (Chapter 2), the psychometric properties of 
the PQ were established using an all-clinical outpatient sample. More specifically, the 
validity of the theoretically defined factor structure of the OQ-45.2 was tested using 
Confirmatory Factor Analysis (CFA) in the sample of PQ data. In addition, estimates of 
internal consistency were calculated and expected to be consistent with those existing in 
the literature for the OQ-45.2. 
 In Study 2 (Chapter 3), the psychometric properties of the OQ-45.2 were 
evaluated using an all-clinical sample of outpatient data. Similarly to Study 1, this was 
accomplished through CFA. The internal consistency of the OQ-45.2 items was 
estimated, and expected to be consistent with previous findings. In addition, the 
measure’s test-retest reliability was calculated across varying time intervals between 
administrations. The temporal stability was also expected to be consistent with previous 
findings. 
The purpose of Study 3 (Chapter 4) was to further the aims of Study 2 by 
examining the temporal construct stability of the factor structure of the OQ-45.2. That is, 
as an indicator of construct validity, the factor structure of the OQ-45.2 was examined at 
baseline and fourth administration to determine whether the two are consistent. It was 
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expected that the underlying factor structure of the measure would be consistent from the 
first to the fourth administration. While this question has not been specifically addressed 
in prior literature, it is considered to be an important aspect of construct validity. Because 
data collected with the OQ-45.2 may ultimately be utilized to make decisions about 
consumers’ treatment, it is important to address this issue to ensure the construct validity 
of the OQ-45.2. This was accomplished through CFA. 
Finally, the fourth aim of the study was to qualitatively evaluate the 
implementation usability of the PQ in an outpatient clinical setting. As previously 
discussed, the overall aim of patient- focused research is the ongoing measurement of 
patient progress with minimally increased burden on office staff and providers. The 
degree to which this aim was accomplished is discussed in Chapter 5. 
1.8. Summary 
 The patient- focused research methodology was discussed in light of efficacy and 
effectiveness research approaches. This methodology was applied in a managed care 
setting, the method of outcome evaluation for which was an adaptation of the Outcome 
Questionnaire, the Progress Questionnaire. The present study is a psychometric 
investigation of the PQ. While the OQ-45.2 possesses desirable reliability and validity 
characteristics, studies conducted thus far possess significant limitations. In addition, the 
importance and requirement of re-evaluation of an instrument’s operating characteristics 
subsequent to item modification has been discussed. Thus, and consistent with the 
recommendations of several authors, the primary aim of this study is demonstration of the 
reliability and validity characteristics of the PQ in an all clinical sample. More 
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specifically, this entails estimation of internal consistency, test-retest reliability, and 
estimation of construct validity through confirmatory factor analysis. 
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 2.1.1. Participants 
 The total sample (N = 278) consisted of new patients presenting to the outpatient 
clinic at Friends Hospital in Philadelphia for psychotherapy and/or medication 
management services between September, 2001, and December, 2001. Participants 
completed a demographics questionnaire along with the PQ. Demographic data were not 
available for a substantial portion of the sample as this questionnaire was not included in 
the original group of intake packets. In addition, some demographics questionnaires 
contained missing data. Table 1 presents the available sample descriptive statistics for 
participant age, sex, and race. 
 
 
Table 1: PQ Sample Demographics 





Sex (N = 278) n (%) 
Male 107 (38%) 
Female 149  (54%) 
Unavailable 22  (8%) 
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Table 1: PQ Sample Demographics 
(continued) 
Race (N = 278)  
Caucasian 87  (31%) 
African-American 44  (16%) 
Hispanic 13  (5%) 
Asian/Pacific Islander 4  (1%) 
Other 2  (.7%) 
White-Native American 2  (.7%) 




 Descriptive statistics pertaining to patient diagnosis are presented in Table 2. 
Diagnoses were available for 194 patients (70%); however, it should be noted that this 
data is of limited utility as a substantial proportion (30%) of these are deferred diagnoses. 
This is the result of the guidelines of the Managed Behavioral Healthcare Organization 
(MBHO), which permit clinicians to assign a diagnosis of 799.9, Diagnosis Deferred, at 




Table 2: PQ Sample Primary Diagnosis 
Diagnosis n (%) 
Depressive Disorder 83 (30%) 
Diagnosis Missing 83 (30%) 
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Table 2: PQ Sample Primary Diagnosis 
(continued) 
Diagnosis n (%) 
Diagnosis Deferred 83 (30%) 
Anxiety Disorder 20 (7%) 
Schizophrenia 5 (2%) 




 2.1.2. Measure 
 As previously stated, the measure evaluated in this study was the Progress 
Questionnaire (PQ; See Appendix A). This measure is based predominantly on the 
Outcome Questionnaire (Lambert et al., 1996), and there are currently no psychometric 
data available on the PQ. The PQ contains fifteen new items for a total of 60 items and 
requires approximately 7-9 minutes for completion. The PQ is a paper-and-pencil 
questionnaire completed by darkening a response choice circle with a pencil. The 
responses were entered into an electronic database for data analysis by hand. Items 1-45 
of the PQ are identical to the items of the OQ-45.2 in order, wording, and format. Items 
46-60 were added by the MBHO. These items are of theoretically consistent content to 
the items of the OQ-45.2, possess the original scale, and were deemed by the MBHO to 
be significant additions to the existing OQ-45.2 items because they increase the breadth 
of diagnostic, symptom, and functioning-related items considered theoretically consistent 
with the existing factor structure of the OQ-45.2. 
Instructions for the PQ are identical to those of the original OQ-45.2 and ask the 
participant to respond to the items, looking back over the last week. In the instructions, 
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the stated purpose of the questionnaire is to “help us understand how you have been 
feeling.” 
All items of the PQ are answered on a five point scale identical to that of the OQ-
45.2: 0=Never, 1=Rarely, 2=Sometimes, 3=Frequently, and 4=Almost Always. Examples 
of original OQ-45.2 items include: “I feel nervous,” “I am satisfied with my relationships 
with others,” “I feel stressed at work/school.” Examples of the new PQ items include: “I 
have thoughts of hurting other people,” “I see and hear things that other people do not see 
or hear and that might really not be there,” and “I have panic or anxiety attacks that come 
suddenly out of the blue.” 
The number of missing items allowable on the PQ before declaring an invalid 
protocol was set at 7 or more missing items. This was based on scoring guidelines for the 
original OQ (Maureen Hart, personal communication, September 6, 2002) which permits 
five or less missing responses. Two additional missing items were allowed for the PQ due 
to the addition of 15 new questions. 
 2.1.3. Design & Procedures 
This investigation was a unique evaluation of the PQ that would otherwise have 
not been conducted. That is, the purpose, rationale, hypotheses, and analyses of this study 
were proposed by this author to the quality improvement department and research 
committee at the MBHO. In the absence of this study, the psychometric characteristics of 
the PQ would not have been estimated, examined, or reported. 
The global aim of the procedures outlined below was to allow for thorough 
investigation of the psychometric properties of the PQ as used in actual outpatient clinical 
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practice. Data collected were used to evaluate the factor structure and other estimates of 
reliability and validity of the PQ. 
 Individuals who sought services at the site described above completed the PQ as 
part of the standard intake paperwork immediately upon arrival to their first session. 
Questionnaires were provided to all patients by front desk staff as part of the standard 
new patient procedure. That is, participants arrived to their initial appointments and 
completed the questionnaire as one component of a standard packet of intake documents. 
The forms were returned to the receptionist immediately upon completion and prior to the 
appointment. This represents the baseline, and only, administration of the questionnaire 
to this sample. 
2.2. Results: Psychometric Properties of the Progress Questionnaire  
 The analyses presented below are based on the sample described above. That is, 
baseline data for 278 patients presenting for outpatient treatment during the data 
collection period were examined. Because the overall aim of this investigation was 
psychometric evaluation of the PQ in the context of a patient- focused research project, 
descriptive data pertaining to the logistical aspects of the questionnaire are important as 
they provide some indication of the usability of the measure. Such results assist in the 
identification of areas for further questionnaire, staff training, and patient- focused 
research development. Presented below are the PQ descriptive statistics. 
 2.2.1. PQ Descriptive Statistics 
 Questionnaire completion. The PQ was provided to a total of 371 new patients. Of 
these, 75% (n = 278) were useable for analysis. The remaining 25% (n = 93) were not 
useable for at least one of three reasons. In 54% (n = 50) of unusable cases, office staff 
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inadvertently provided patients under the age of 18 with the PQ as part of the standard 
intake packet despite their minor status. In 40% (n = 37) of unusable cases, the 
questionnaire was deemed invalid on the basis of missing data. Finally, in 6% (n = 6) of 
unusable cases, complete data were not available due to one or more pages missing from 
the PQ. Thus, the final sample submitted for analysis was comprised of 278 usable cases. 
 Data entry integrity check. All data were entered into a Microsoft Access 2002 
database and then converted into an SPSS format data file for analysis with SPSS 10.0.5 
and AMOS 4.0. Based on the recommendation of Kazdin (1998), the accuracy of entered 
data was first assessed by selecting a random sample of 20% (n = 56) of entered cases 
and manually comparing the values entered into the database with those recorded by the 
patient on the paper questionnaire. Of 3,360 data points (56 PQ’s with 60 items each), 
two items (.06%) were entered incorrectly. Thus, of 56 cases, 54 (96%) had all data 
entered correctly. Based on this finding, no additional cases were selected for data entry 
accuracy checking. 
 With respect to the database, it should also be noted that nine PQ items are 
reverse scored. This transformation was directly implemented during the data entry stage 
by associating the response item with the reverse score. Therefore, in subsequent analyses 
and interpretation, all items are coded in the same direction, such that a high score on any 
item reflects greater symptomatology or impairment in functioning. For example, after 
being reverse scored, a high score on PQ01, “I get along well with others,” reflects 
increasing relationship difficulty. 
Missing data. Inspection of the PQ data revealed a substantial amount of missing 
data. A total of 376 data points (2.25% of all possible responses) were missing. The 
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average number of missing items on each PQ administration was 1.35 (SD = 2.22) of 60. 
A total of 126 (45%) cases had at least one missing data point. Of cases with missing 
data, the majority, 98 (78%), were missing four or fewer items. 
 Inspection of the most frequently missing PQ items revealed similar question 
content. Table 3 contains these items and the percentage of cases in which each is 
missing. It appears that the most frequently missing items are those that do not apply to 
some patients, in contrast to items such as “I like myself” or “I feel blue” that is readily 
applicable to all patients. It should also be noted that these items were, on multiple 
occasions, accompanied by written notes on the questionnaire such as “N/A” or for work 
related items, “I don’t work.” 
 
 
Table 3: Frequently Missing PQ Items 
PQ # Question % Missing (n) 
07 I feel unhappy in my marriage/significant relationship  12.2% (34) 
48 I have crises where I call my therapist  10.1% (28) 
17 I have an unfulfilling sex life  9.4% (26) 
57 I am taking my medication exactly as prescribed  9.4% (26) 
12 I find my work/school satisfying  8.6% (24) 
39 I have too many disagreements at work/school  7.2% (20) 
38 I feel that I am not doing well at work/school  6.8% (19) 
04 I feel stressed at work/school  6.5% (18) 
28 I am not working/studying as well as I used to  6.1% (17) 
44 I feel angry enough at work/school to do something I may regret  5.4% (15) 
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Table 3: Frequently Missing PQ Items (continued) 
PQ # Question % Missing (n) 
50 I have days where I am less productive at work 5.0% (14) 




 Because the original OQ-45.2 was written and coded such that a response of zero 
indicates “Never” or “Does Not Apply,” the above items were recoded from missing to 
zero. Following this, none of the 278 questionnaires had greater than five missing items. 
This leaves a total of 74 missing data points (.4%). 
 Gorsuch (1983) recommends the use of a regression-based method for the 
estimation of missing data points. The SPSS Missing Value Analysis Regression 
subcommand was used to estimate missing items through multiple regression equations 
(SPSS, 1997). Though AMOS is equipped to handle missing data through its own 
procedure (Byrne, 2001), the decision was made to utilize regression based imputation so 
as to provide a complete and consistent dataset to be used in other analyses. Thus, 
following this procedure, a complete set of data was available for analysis. 
 2.2.2. PQ Internal Consistency 
 Cronbach’s Coefficient Alpha was computed using SPSS Reliability Analysis to 
assess the internal consistency of the PQ. Results for the PQ total score as well as the 
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Table 4: PQ Total and Subscale Internal Consistency Values 
PQ Scale Internal Consistency  
(N = 278) 
PQ Total  .95 
Symptoms Distress (SD)  .93 
Interpersonal Relationships (IR)  .80 




 2.2.3. PQ Three Factor CFA 
 The purpose of this analysis was to provide an empirical test of the plausibility of 
the theoretically derived three-factor structure of the modified version of the OQ-45.2, 
the PQ. The three-factor model tested is described below. 
 Variables removed from analyses. Three of the fifteen new variables were 
removed from subsequent analyses on theoretical grounds. Each item was deemed 
theoretically inappropriate for the PQ due to its presupposition of current psychiatric 
and/or psychotherapy services. These items were: PQ48 (“I have crises where I call my 
therapist”), PQ56 (“I take medications for mental health problems”), and PQ57 (“I take 
my medication exactly as prescribed”). In addition, PQ56 is inconsistent with the scaled 
response choices due to its dichotomous nature.  
 Conceptual model. This is a confirmatory factor analysis model achieved through 
structural equation modeling. As previously noted, the OQ-45.2 was constructed with 
three theoretically derived subscales. The SD subscale is comprised of the following 
items: PQ02, PQ03, PQ05, PQ06, PQ08, PQ09, PQ10, PQ11, PQ13, PQ15, PQ22, PQ23, 
PQ24, PQ25, PQ27, PQ29, PQ31, PQ33, PQ34, PQ35, PQ36, PQ40, PQ41, PQ42, PQ45, 
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PQ46, PQ47, PQ49, PQ51, PQ52, PQ53, PQ54, PQ55, PQ58, PQ59, and PQ60. The IR 
subscale is comprised of the following items: PQ01, PQ07, PQ16, PQ17, PQ18, PQ19, 
PQ20, PQ26, PQ30, PQ37, and PQ43. The SR subscale is comprised of the following 
items: PQ04, PQ12, PQ14, PQ21, PQ28, PQ32, PQ38, PQ39, PQ44, and PQ50. 
According to the model tested below, the PQ is a measure of three latent 
constructs, SD, IR, and SR, each represented by ellipses in the path diagram. Each 
construct is defined by a number of observed indicators, as represented by rectangles in 
the path diagram (See Figure 1). The relationship between the construct and the observed 
variable is represented by a straight arrow. Additionally, the model specifies that all pairs 
of the three latent constructs are correlated. Finally, associated with each observed 
indicator is an error term, represented by an ellipse, which represents the unique variance 
associated with each question. Thus, this is a conceptual representation of the 
theoretically derived factor structure of the PQ, and subsequent analysis will provide a 
measure of the extent to which the sample data support this model. 
 Statistical model. Considering the above model at a statistical level, there are a 
total of 57 observed indicator variables (PQ01-PQ60, with PQ48, PQ56, and PQ57 
removed), 60 unobserved variables (the three latent constructs and the 57 unobserved 
error terms associated with the PQ items), for a total of 117 variables in the model. This 
yields 57 free parameters and 60 fixed parameters. Thus, the c2 test for the overall 
goodness of fit of this model is based on 1653 sample moments, 117 parameters to be 
estimated, and 1536 degrees of freedom.  
 
 


























 Figure 1: Path Diagram of the PQ Interpersonal 
 Relationships Factor 
 
 
Matrix to be analyzed. Based on current practices in SEM, the following analysis 
was based on the covariance matrices of the observed data. Because covariances do not 
represent meaningful units for visual inspection, the bivariate correlation matrix and 
standard deviations for all PQ items are frequently reported. However, due to the large 
number of variables in the present analysis, this information has been omitted and is 
available upon request. 
 An additional issue relating to the practice of SEM with psychological data is the 
controversy surrounding the typical treatment of categorical variables as continuous for 
analyses based in structural equation modeling. While debate exists, based on the 
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recommendations of Byrne (2001), as well as standard practice, the data in the analyses 
below were treated as continuous. 
 Distribution of data. An important assumption in SEM analyses, such as CFA, is 
that the data to be analyzed follow a multivariate normal distribution (Kline, 1998). There 
are two primary methods of making this determination. First, examination of univariate 
normality estimates, namely skewness and kurtosis, provides details of the distribution 
characteristics of each variable. The existence of individual variables departing 
significantly from a univariate normal distribution prohibits the existence of multivariate 
normality (West et al., 1995). In other words, the condition of multivariate normality 
presupposes univariate normality. Second, the condition of univariate normality does not 
guarantee multivariate normality. Thus, given univariate normality, conditions of 
multivariate skewness or kurtosis may still exist. 
Univariate estimates of skewness and kurtosis were obtained through SPSS 
Descriptives and, the variables with significant departures from normality are 
summarized in Table 5 below. Kline (1998) argues that skewness values in excess of ±3 
and kurtosis values in excess of ±10 represent significantly non-normal univariate 
distributions. Likewise, he recommends that kurtosis values in excess ±20 represent 
severe departures from univariate normality. Accordingly, of the 60 PQ items, two 
variables had significant levels of univariate skewness and kurtosis. The items are: PQ11 
(“After heavy drinking, I need a drink the next morning to get going”) and PQ32 (“I have 
trouble at work/school because of drinking or drug use”). 
These variables were transformed so as to decrease their departures from 
univariate normality. As recommended by Kline (1998) and Hair et al. (1995), the 
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selected transformation, provided the degree of positive skew, was 1/(X+1). See Table 5 
for the original and transformed skewness and kurtosis values. 
 
 
Table 5: Non-Normally Distributed PQ Items 
PQ Item Skewness Kurtosis 
PQ11  3.10  10.35 
PQ32  3.27  10.78 
PQ11 Transformed  -1.19  4.99 




 Multivariate kurtosis was assessed by Mardia’s test of multivariate normality 
which was provided by AMOS (Byrne, 2001; Mardia, 1970). Various sources suggest 
that large values, e.g., those greater than 30, should be considered significant departures 
from multivariate normality (see Newsom, 2001; Byrne, 1995; and Byrne, 2001). 
Mardia’s measure of multivariate kurtosis was 296.581, the critical ratio of which was 
30.148. Based on the above guidelines, this indicates that the PQ data are significantly 
multivariate non-normal. 
 Model estimation and fit criteria. The model parameters in the following analyses 
were estimated through the Maximum Likelihood (ML) method. This decision stems 
from the recommendations of multiple authors for most analyses based on SEM (e.g., 
Chou & Bentler, 1995; Hoyle & Panter, 1995). There are numerous reasons for this 
decision, among them, ML estimation is frequently employed in SEM analyses, has 
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demonstrated robustness with respect to violation of the conditions of normality, and 
possesses reasonable sample size requirements (Chou & Bentler). 
 Below is a brief presentation of the fit indexes utilized in these analyses for the 
purpose of determining the adequacy of model fit. This includes the definition of each 
and explication of the critical values against which each was evaluated. There are two 
basic categories of fit indexes, absolute fit indexes and incremental fit indexes (Hoyle & 
Panter, 1995). The former is a measure of the degree to which a pre-specified structural 
model reproduces the sample data. Accordingly, they can be considered measures of the 
“badness of fit” of a particular model (Hoyle & Panter, p. 165). Conversely, the latter is 
an indication of the model “goodness of fit,” or the extent to which the specified model 
provides improved fit when compared to a model with no relationships among the 
variables (Hoyle & Panter, p. 165). The authors recommend reporting at least one 
absolute fit index along with two or more incremental fit indexes. 
 The Chi-Square was used as an absolute index of fit. The chi-square statistic tests 
the lack of fit of the theoretical model tested. Therefore, rejection of the null hypothesis 
(p > .05) is interpreted as a model that does not fit the observed data well, that is, a non-
plausible model. However, it should be noted that a known limitation of this test is that 
the c2 is quite sensitive to sample size and assumes perfect model fit, frequently resulting 
in rejected models (Byrne, 2001). 
 The most consistently performing indicator of absolute fit is the goodness of fit 
index (GFI). The GFI represents the relative amount of variances and covariances 
expected by the implied model that is accounted for by the observed data. Thus, the value 
of the GFI is similar in nature and interpretation to the value of an R2 value in regression 
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analyses (Hoyle & Panter, 1995). The maximum value of the GFI is 1, though the index 
can be less than 0. A value of one indicates that the observed variances and covariances 
are identical to those anticipated by the theoretical model. In this investigation, a GFI 
cutoff score of .90 was used to identify a plausible model, with values below this cutoff 
suggesting an implausible model. 
 The Comparative Fit Index (CFI) was also used to evaluate model fit. The CFI is 
based on an adaptation of the normed fit index (NFI) that considers the influence of 
sample size when comparing the hypothesized model to the independence model (Byrne, 
2001). Based on the recommendation of Byrne, a cutoff value of .95 was used to consider 
the model well- fitting. 
 The Tucker-Lewis Index (TLI) was also used to evaluate model fit. The TLI is 
similar in interpretation to the previous measures of goodness of fit presented here 
(Byrne, 2001). A cutoff score of .95 was used to consider the model well- fitting. 
Parameter estimates. According to Byrne (2001), the CFA results should initially 
be examined so as to determine the feasibility of obtained parameter estimates. Likewise, 
adequate parameter estimates can be identified by statistically significant critical ratios, 
i.e. C.R. in excess of ±1.96, for the regression weights, covariances, and variances 
(Byrne). Removal of any variables falling in the non-significant range is recommended. 
Examination of the parameter estimates revealed that all critical ratios were statistically 
significant. In addition, as is desirable, visual inspection of the standardized regression 
coefficients revealed no Heywood cases (i.e., coefficients greater than 1 or negative 
variances). All variables were retained for further analysis. Parameter estimates are 
included in Appendix B. 
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Because of the excessively kurtotic nature of the data, the bootstrapping 
procedure was employed as recommended by Byrne (2001). The bootstrap procedure 
involves the selection random samples with replacement from the sample data, yielding a 
sample-specific empirically-based normal sampling distribution (West et al., 1995). 
Parameter estimates are based on this distribution in the presence of violated SEM 
assumptions, such that the accuracy of the parameter estimates is markedly improved. 
The parameter estimates obtained through the bootstrapping procedure are omitted due to 
space considerations and are available upon request. 
 Evaluation of model fit. The overall test of model fit indicated that the 
theoretically derived three factor model was not plausible based on the observed data, 
c2(1536, N = 278) = 4028.393, p = .0001, GFI = .616, TLI = .643, and CFI = .656. Given 
the excessively kurtotic nature of the data, the c2 was also calculated according to the 
Bollen-Stine bootstrap method (Byrne, 2001), p = .002. Thus, even when accounting for 
the non-normality present in the data, the model tested remains implausible. 
 Model modification. Though AMOS provides two sources of information that can 
be utilized to assess model misspecification and make decisions regarding the 
respecification of model parameters (i.e., standardized residuals and modification 
indexes), the model tested above was not modified in this analysis. This decision was 
made on the basis of multiple authors, and the primary reasons are briefly addressed 
below. 
First, the exceedingly poor fit of the three factor model just tested suggests that 
the entire model should be respecified. This falls beyond the scope of modification 
indexes. Second, modified models run the risk of capitalizing on the sample-specific 
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characteristics of the data matrix (Hoyle & Panter, 1995). Thus, they must be tested on a 
distinct sample to account for these concerns; however, the sample size of the present 
study does not permit the execution of this procedure. Similarly, substantive changes to 
the specified model should be based in theory rather than empirical indicators of fit, as a 
purely empirically driven modification is unlikely to yield an accurate model (Kline, 
1998). In this case, the theoretical basis for the three factor structure appears to be 
inadequate and no other theory is offered. Another reason provided for not modifying the 
model is that, with the exception of very large sample sizes, the modifications are 
unlikely to replicated (MacCallum, Roznowski, & Necowitz, 1992).  
 Given the poor fit of the sample data to the theoretical model just described, the 
focus shifts to an examination of a more appropriate factor specification for the PQ. 
However, it must be noted explicitly that, at this stage, the analyses change from a 
confirmatory approach to an exploratory approach (Byrne, 2001). That is, beyond this 
stage of analysis all results are considered exploratory as the analyses are not driven by 
theory. The PQ sample data were submitted to an exploratory factor analysis. Results are 
presented below. 
 2.2.4. Exploratory Derivation of the PQ Factor Structure  
 A principle components analysis (PCA) with Promax rotation was performed 
using SPSS Factor Analysis. The oblique rotation method was selected on the basis of 
recommendations by Hair et al. (1995) and Gorsuch (1983), who argue that oblique 
methods are entirely appropriate when the purpose of the analysis is identification of a 
factor structure in which the latent factors would be expected to be correlated. This is the 
case in the present investigation. 
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 Prior to conducting a PCA, the bivariate correlation matrix was inspected for 
correlations greater than or equal to .30, as guidelines suggest that a moderate portion of 
the correlations should fall in this range (Hair et al., 1995). Inspection of the correlations 
revealed that approximately 31% (i.e., 547 of 1770) were at least .30 in magnitude. When 
considering the entire correlation matrix, the average correlation was .31. 
 In addition, residuals were examined in order to determine the amount of 
correlation remaining between variables when the effects of the other variables removed 
(Hair et al., 1995). Ideally, this is a small value, suggesting a high degree of 
intercorrelation among the variables. Examination of the residuals revealed that 23.5% 
are greater in absolute value than .10, 3.4% of which were greater than .20, and .6% of 
which were greater than .30. Thus, with the effects of the other variables are removed, 
only a small portion of variables retain a significant bivariate relationship. This is a 
desirable condition for factor ana lysis. 
The Measure of Sampling Adequacy (MSA) values, an additional indication of 
the extent of intercorrelation among variables and the suitability of the data for factor 
analysis, were also examined (Hair et al., 1995). The authors recommend that variables 
with MSA values falling in the unacceptable range (i.e., below .50) should be excluded 
from further analysis. Examination of MSA values revealed that one variable, PQ57 (“I 
am taking my medication exactly as prescribed”), fell in the “unacceptable” range with a 
value of .489. In addition, PQ56 (I am taking medication for mental health problems), 
with an MSA value of .544, fell in the “miserable” range. One variable, PQ14 (I 
work/study too much), fell in the “mediocre” range, .617. Six variables fell in the 
“middling” range, and the remaining variables all fell in the “meritorious” or 
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“marvelous” range, .80 and above or .90 and above range, respectively. Thus, PQ items 
56 and 57 were removed from further analysis. In addition, PQ14, fell in the “mediocre” 
range was removed on account of the disparity between it and the MSA levels of the 
remaining variables. Analyses were rerun with these variables removed. All resulting 
MSA values were in the “middling” range or above. 
Three additional variables were excluded from the following analysis. PQ 48 (“I 
have crises where I call my therapist”) was removed on theoretical grounds previously 
described. The remaining items, PQ41 (“I have trouble falling asleep”) and PQ58 (“I 
see/hear things that other people do not see/hear”) were removed from the analysis due to 
low communality values, .461 and .341, as recommended by Hair et al. (1995). Thus, a 
dataset comprised of 54 items was submitted for final analysis.  
 Prior to final analysis, a check on the quality of the correlation matrix for 
factoring was conducted using the Kaiser-Meyer-Olkin (KMO) Measure of Sampling 
Adequacy and Bartlett’s Test of Sphericity. Bartlett’s Test of Sphericity provides a 
description of the adequacy of the data for the purpose of factor analysis. In other words, 
it is the probability that the observed data are correlated to a significant degree (Hair et 
al., 1995). The KMO = .912, which indicates that the correlation matrix is in excellent 
condition for factoring, and Bartlett’s Test of Sphericity was significant, c2 (1431) = 
7856.274, p = .0001. 
 As warned by Hair et al. (1995), PCA in excess of fifty variables often yields a 
large number of factors, the latter of which are regularly poorly defined by one or two 
variables. Indeed, following the latent root criterion, thirteen factors were extracted with 
eigenvalues greater than one. Because the latter factors were poorly defined, the 
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determination was made to limit the number of factors to be interpreted by extracting the 
number needed to account for approximately 60% of the variance, as discussed in Hair et 




Table 6: PQ PCA Communalities 
Question Initial Extraction  Question Initial Extraction 
PQ01 1.000 .651  PQ09 1.000 .681 
PQ02 1.000 .533  PQ10 1.000 .658 
PQ03 1.000 .605  PQ11 1.000 .675 
PQ04 1.000 .644  PQ12 1.000 .538 
PQ05 1.000 .570  PQ13 1.000 .632 
PQ06 1.000 .617  PQ15 1.000 .692 
PQ07  1.000 .557  PQ16 1.000 .507 
PQ08 1.000 .560  PQ17 1.000 .621 
PQ18 1.000 .613  PQ38 1.000 .724 
PQ19 1.000 .654  PQ39 1.000 .615 
PQ20 1.000 .600  PQ40 1.000 .626 
PQ21 1.000 .517  PQ42 1.000 .655 
PQ22 1.000 .501  PQ43 1.000 .622 
PQ23 1.000 .668  PQ44 1.000 .664 
PQ24 1.000 .540  PQ45 1.000 .612 
PQ25 1.000 .621  PQ46 1.000 .594 
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Table 6: PQ PCA Communalities (continued) 
Question Initial Extraction  Question Initial Extraction 
PQ26 1.000 .628  PQ47 1.000 .546 
PQ27 1.000 .611  PQ49 1.000 .592 
PQ28 1.000 .697  PQ50 1.000 .587 
PQ29 1.000 .538  PQ51 1.000 .519 
PQ30 1.000 .653  PQ52 1.000 .554 
PQ31 1.000 .675  PQ53 1.000 .605 
PQ32 1.000 .691  PQ54 1.000 .535 
PQ33 1.000 .642  PQ55 1.000 .629 
PQ34 1.000 .531  PQ59 1.000 .649 
PQ35 1.000 .575  PQ60 1.000 .581 
PQ36 1.000 .681     




Ten factors with eigenvalues greater than 1 were extracted, accounting for 60.9% 
of the variance. This solution was submitted to Promax rotation, and the rotated factor 
solution converged in sixteen iterations. The factors were defined and interpreted based 
on the Factor Pattern Matrix, see Appendix C for individual variable loadings. The Factor 
Structure Matrix is also presented in Appendix C. 
The factors were defined as follows: I. Depression. This factor accounted for 
29.2% of the variance and is comprised of the following seventeen items: 25, 23, 08, 05, 
40, 42, 15, 33, 06, 21, 09, 55, 24, 22, 03, 18, and 60. II. Interpersonal Satisfaction. This 
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factor accounted for 6% of the variance and is comprised of the following eight items: 01, 
13, 43, 37, 20, 30, 31, and 12. III. Somatic Complaints. This factor accounted for 4.8% of 
the variance and is comprised of the following six items: 45, 27, 34, 02, 29, and 51. IV. 
Anxiety. This factor accounted for 4.2% of the variance and is comprised of the following 
five items: 35, 59, 36, 10, and 47. V. Primary Role Dysfunction. This factor accounted for 
3.4% of the variance and is comprised of the following five items: 38, 28, 04, 50, and 39. 
VI. Alcohol Misuse. This factor accounted for 3.2% of the variance and is comprised of 
the following three items: 11, 32, and 26. VII. Love Relationship Distress. This factor 
accounted for 2.9% of the variance and is comprised of the following three items: 17, 07, 
and 16. VIII. Dangerousness. This factor accounted for 2.8% of the va riance and is 
comprised of the following three items: 49, 44, and 46. IX. Agitation. This factor 
accounted for 2.3% of the variance and is comprised of the following two items: 19 and 
54. X. Psychomotor Disturbance. This factor accounted for 2.1% of the variance and is 
comprised of the following two items: 52 and 53. 
 Validation of this empirically derived factor structure through CFA was not 
possible due to sample size limitations. That is, the sample size did not permit the 
retention of an independent subsample of data for such an analysis. 
For this study, data were to be collected across multiple administrations of the 
PQ; however, immediately following collection of the data analyzed above, the outpatient 
facility where they were collected closed. Thus, to permit fulfillment of the original aims 
of this study, a supplementary dataset was obtained from OQ Systems, Inc., the company 
that licenses the rights to the OQ-45.2. 
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 3.1.1. Participants 
 A large sample of data (N = 17,978) was obtained through OQ Systems, Inc., the 
company that licenses the outcomes management system. Participants were individuals 
who were receiving outpatient mental health services between November 1, 1998 and 
February 28, 2002. The database contains repeated measurements for some patients. 
Descriptive data pertaining to the number of OQ-45.2 administrations are presented in 
Table 7. However, no other demographic and descriptive data were available on the 
participants in this study. Random samples were drawn from the database in order to 
supply the sample data for analyses presented below. 
 For each analysis, a sample of 450 cases was drawn randomly from the 13,502 
baseline administrations of the OQ-45.2 using SPSS Select Cases. This sample size was 
selected on the basis of available guidelines for sample sizes in factor analytic and SEM 
analyses, here 10 observations per variable (Kline, 1998).  
 
 
Table 7: OQ45.2 
Administrations 
# N (%) 
1  13,502 (75%) 
2  2,483 (14%) 
3  801 (4%) 
4  398 (2%) 
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Table 7: OQ45.2 
Administrations 
(continued) 
# N (%) 
5  251 (1%) 
6  156 (.9%) 
7  106 (.6%) 




3.1.2. Measure  
 The measure being investigated in Study 2 is the Outcome Questionnaire (OQ-
45.2; See Appendix C). The OQ-45.2 and its psychometric properties is described 
thoroughly in Chapter 1. The measure is available in multiple administration methods: 
Paper-and-pencil, telephone (IVR), internet, computer, and handheld device. Associated 
with each data collection method is a data entry method, including: manual, scanning, 
direct, and Hotsync entry. The questionnaire instructions and response choices are 
identical to those described in Study 1. 
 3.1.3. Design & Procedures 
Specific data collection procedures are not available for this study as a result of 
the multiple sources of data contributing to the complete data set. All data were collected 
in outpatient clinical settings throughout the United States using one of the available 
administration and data entry methods just described. 
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3.2. Results (Random Sample 1) 
 3.2.1 Descriptive Statistics 
 Questionnaire completion and data integrity. The dataset just described contains 
no missing data points. Each patient’s questionnaire was entered by OQ Systems, Inc. 
directly into an electronic database and scored automatically. Greater than five missing 
responses resulted in an invalid profile, and the missing items on questionnaires with five 
or fewer missing were estimated based on the patients’ responses to the remaining 
questions (Maureen Hart, personal communication, September 6, 2002). 
 3.2.2. Internal Consistency 
Cronbach’s Coefficient Alpha was computed using SPSS Reliability Analysis to 
assess the internal consistency of the OQ-45.2. Results for the three theoretically derived 
subscales of the OQ-45.2 (SD, IR, and SR) are presented in Table 8. 
 
 




(N = 13,502) 
Symptoms distress .932 
Interpersonal relationships .802 
Social role .740 
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Additionally, Cronbach’s Coefficient Alpha was computed for additional administrations 
of the OQ-45.2. Results are presented in Table 9 for the theoretical subscales as well as 
the OQ Total score. 
 
 
Table 9: OQ-45.2 2nd to 5th Assessment  
Internal Consistency 
2nd Assessment (n = 2483) 
OQ-45.2 Scale Internal consistency 
Symptoms Distress .939 
Interpersonal Relationships .808 
Social Role .762 
OQ Total .947 
3rd Assessment (n = 801) 
Symptoms Distress .946 
Interpersonal Relationships .812 
Social Role .781 
OQ Total .951 
4th Assessment (n = 398) 
Symptoms Distress .948 
Interpersonal Relationships .808 
Social Role .775 
OQ Total .952 
5th Assessment (n = 251) 
Symptoms Distress .950 
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Table 9: OQ-45.2 2nd to 5th Assessment  
Internal Consistency (continued) 
5th Assessment (n = 251) 
Interpersonal Relationships .833 
Social Role .793 




 3.2.3. Test-Retest Reliability 
Test-retest reliability was examined first in cases with a one week interval 
between OQ-45.2 administrations. Test-retest reliability was calculated as the bivariate 
correlation coefficient between the OQ-45.2 subscale and total scores for the first and 
second administrations of the questionnaire. Results are presented in Table 10 below.  
 
 
Table 10: OQ-45.2 Test-Retest Reliability 
1 Week Interval (N = 1281) 
OQ-45.2 Scale Pearson r 
Symptoms Distress .800, p = .01 
Interpersonal Relationships .764, p = .01 
Social Role .725, p = .01 
OQ Total .786, p = .01 
2 Week Interval (N = 470) 
Symptoms Distress .747, p = .01 
Interpersonal Relationships .744, p = .01 
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Table 10: OQ-45.2 Test-Retest Reliability 
(continued) 
OQ-45.2 Scale Pearson r 
Social Role .675, p = .01 
OQ Total .739, p = .01 
3 Week Interval (N = 296) 
Symptoms distress .647, p = .01 
Interpersonal relationships .625, p = .01 
Social role .580, p = .01 
OQ total .618, p = .01 
4 Week Interval (N = 188) 
Symptoms distress .843, p = .01 
Interpersonal Relationships .709, p = .01 
Social role .771, p = .01 
OQ total .821, p = .01 
5 Week Interval (N = 133) 
Symptoms Distress .726, p = .01 
Interpersonal Relationships .745, p = .01 
Social role .660, p = .01 




3.2.4. OQ-45.2 Three Factor CFA 
 Conceptual model. The conceptual model tested in this analysis was identical to 
that previously described for the PQ, though only utilizing the original 45 items of the 
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OQ-45.2. The SD subscale is comprised of the following items: PQ02, PQ03, PQ05, 
PQ06, PQ08, PQ09, PQ10, PQ11, PQ13, PQ15, PQ22, PQ23, PQ24, PQ25, PQ27, PQ29, 
PQ31, PQ33, PQ34, PQ35, PQ36, PQ40, PQ41, PQ42, and PQ45. The IR subscale is 
comprised of the following items: PQ01, PQ07, PQ16, PQ17, PQ18, PQ19, PQ20, PQ26, 
PQ30, PQ37, and PQ43. Likewise, the SR subscale is comprised of the following items: 
PQ04, PQ12, PQ14, PQ21, PQ28, PQ32, PQ38, PQ39, and PQ44. See the conceptual 
model description of the PQ for further details on the model tested below. 
 Statistical model. The statistical model was likewise similar to that presented 
above, with the absence of the additional items. In this model, there were a total of 45 
observed indicator variables (OQ01-OQ45), 48 unobserved variables (three latent 
constructs and 45 error terms associated with each OQ-45.2 item), for a total of 93 
variables in the model. This yielded a total of 45 free parameters and 63 fixed parameters. 
Thus, the c2 test for the overall fit of the model was based on 1,035 sample moments, 93 
parameters to be estimated, and 942 degrees of freedom. 
 Matrix to be analyzed. Analyses below were based on the covariance matrices of 
a random sample of 450 baseline OQ-45.2 administrations. Due to the large number of 
variables in the present analysis, the bivariate correlation matrix and standard deviations 
have been omitted and are available upon request. 
Distribution of data. Univariate estimates of skewness and kurtosis were obtained 
through SPSS Descriptives and are summarized below. The same guidelines as 
previously described were used to determine significance. Three variables were found to 
significantly depart from univariate normality in terms of skewness and kurtosis. The 
three variables are those pertaining to alcohol misuse (PQ11, PQ26, and PQ32). These 
  53 
 
variables were transformed so as to decrease their departures from univariate normality. 
See Table 11 for the original and transformed skewness and kurtosis values. 
 With respect to multivariate normality, Mardia’s measure of multivariate kurtosis 
was 316.498, with a critical ratio of 51.615. This indicates that the multivariate 
distribution of the OQ sample data is significantly non-normal. 
 
 
Table 11: OQ-45.2 Items with Non-Normal 
Distributions 
OQ Item Skewness Kurtosis 
OQ11  3.50  14.06 
OQ26  3.22  10.97 
OQ32  4.58  24.02 
OQ11 Transformed  -2.52  4.67 
OQ26 Transformed  -2.11  3.18 




 Model estimation and fit criteria. Model parameters were estimated through the 
Maximum Likelihood (ML) method. The same fit indexes as above were used to 
determine the degree of fit between the observed data and the theoretically specified 
model. 
 The regression coefficient for one variable, OQ14 (“I work/study too much”) was 
non-significant; accordingly, this variable was removed from subsequent analyses. The 
model parameters are presented in Appendix D. Visual inspection reveals appropriate 
values for the standardized regression coefficients and variances. 
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 Because of the excessively kurtotic nature of the data, the bootstrapping 
procedure was employed. See Study 1 for a description of and rationale for this 
procedure. The Bootstrapping parameter estimates obtained through this procedure are 
omitted due to space considerations and available by request. 
 Evaluation of model fit. The overall test of model fit indicated that the 
theoretically derived three factor model tested here was no t plausible based on the 
observed data, c2(942, N = 450) = 3072.740, p = .0001, GFI = .732, TLI = .760, and CFI 
= .772. The c2 was also evaluated according to the Bollen-Stine bootstrap method and, 
based on the empirically derived normal sampling distribut ion, was still significant, p = 
.002. 
3.2.5. Summary 
 The focus next turned to respecification of the original model such that the sample 
data more closely correspond to the specified model. It must be noted explicitly that, at 
this stage, examination of the factor structure of the OQ-45.2 changes from a 
confirmatory approach to an exploratory approach (Byrne, 2001). Principle components 
analysis was used for this purpose, and, once the empirically derived factor structure was 
obtained, the resulting factor structure was validated through CFA procedures using a 
separate random sample of baseline data.  
3.3. Exploratory Derivation of the OQ-45.2 Factor Structure  
 A Principle Components Analysis (PCA) with Promax rotation was performed on 
the same sample of data using SPSS Factor Analysis. The rationale for selecting these 
procedures was previously described. The bivariate correlation matrix was first inspected 
to establish the degree of variable inter-correlation. Approximately 35% of the observed 
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correlations were at least .30 in magnitude (i.e., 346 of 990). The average correlation 
among all pairs was .24. Of the residuals, 1.4% were greater in absolute value than .10. 
Of these, none were in excess of .20 or .30 in magnitude. Thus, with the effects of the 
other variables removed, only a small portion of variables retained a significant bivariate 
relationship. This is a desirable condition for factor analysis. 
 Univariate MSA values were examined prior to interpretation of the factor 
solution. One variable, OQ14 (“I work/study too much”), fell in the “unacceptable” range 
with a value of .459, and was subsequently removed from further analysis. Also of note, 
the three alcohol misuse related items fell in the “miserable” or “mediocre” range, with 
values of .616, .594, and .621, for OQ11 (“After heavy drinking, I need a drink the next 
morning to get going”), OQ26 (“I feel annoyed by people who criticize my drinking”), 
and OQ32 (“I have trouble at work/school because of drinking or drug use”), 
respectively. These variables were retained for analyses on the basis of the previous PCA 
which suggested that they form a unique factor. Finally, OQ41 (“I have trouble falling 
asleep or staying asleep”) and OQ12 (“I find my work/school satisfying”) were removed 
on the basis of low communalities, .389 and .491, respectively. Thus, a dataset comprised 
of 42 items was submitted for final analysis. 
Prior to final analysis, a check on the quality of the correlation matrix for 
factoring was conducted using the Kaiser-Meyer-Olkin (KMO) Measure of Sampling 
Adequacy and Bartlett’s Test of Sphericity. The KMO = .927, which indicates that the 
correlation matrix is in excellent condition for factoring, and Bartlett’s Test of Sphericity 
was significant, c2 (861) = 8716.109, p = .0001. 
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 The latent root criterion was applied to extract nine factors with eigenvalues 
greater than one (Gorsuch, 1988), accounting for approximately 62% of the variance. The 
average communality value was .617. Communalities are presented in Table 12 below. 
 
 
Table 12: OQ-45.2 PCA Communalities 
Question Initial Extraction  Question Initial Extraction 
OQ01 1.000 .646  OQ23 1.000 .632 
OQ02 1.000 .646  OQ24 1.000 .646 
OQ03 1.000 .584  OQ25 1.000 .551 
OQ04 1.000 .609  OQ26 1.000 .734 
OQ05 1.000 .526  OQ27 1.000 .546 
OQ06 1.000 .664  OQ28 1.000 .700 
OQ07 1.000 .669  OQ29 1.000 .531 
OQ08 1.000 .647  OQ30 1.000 .577 
OQ09 1.000 .616  OQ31 1.000 .694 
OQ10 1.000 .638  OQ32 1.000 .683 
OQ11 1.000 .593  OQ33 1.000 .560 
OQ13 1.000 .655  OQ34 1.000 .570 
OQ15 1.000 .719  OQ35 1.000 .518 
OQ16 1.000 .510  OQ36 1.000 .549 
OQ17 1.000 .581  OQ37 1.000 .600 
OQ18 1.000 .593  OQ38 1.000 .724 
OQ19 1.000 .640  OQ39 1.000 .715 
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Table 12: OQ-45.2 PCA Communalities (continued) 
Question Initial Extraction     
OQ20 1.000 .675  OQ40 1.000 .582 
OQ21 1.000 .516  OQ42 1.000 .647 
OQ22 1.000 .559  OQ43 1.000 .589 
OQ44 1.000 .706     




This solution was submitted to Promax rotation, and the nine factor rotated 
solution converged in thirteen iterations. The factors were defined and interpreted based 
on the Factor Pattern Matrix, see Appendix E1 for individual variable loadings. The 
Factor Structure Matrix is also presented in Appendix E2. The factors were defined as 
follows: I. Depression. This factor accounted for 29.2% of the variance and is comprised 
of the following eleven items: OQ24, OQ13, OQ31, OQ21, OQ43, OQ03, OQ20, OQ23, 
OQ15, and OQ42. II. Anxiety. This factor accounted for 7.0% of the variance and is 
comprised of the following seven items: OQ10, OQ36, OQ33, OQ35, OQ29, OQ25, and 
OQ05. III. Primary Role Dysfunction. This factor accounted for 5.4% of the variance and 
is comprised of the following four items: OQ38, OQ28, OQ04, and OQ39. IV. Love 
Relationship Distress. This factor accounted for 4.6% of the variance and is comprised of 
the following four items: OQ17, QO37, OQ07, and OQ18. V. Somatic Complaints. This 
factor accounted for 3.7% of the variance and is comprised of the following five items: 
OQ02, OQ34, OQ45, OQ27, OQ09, and OQ22. VI. Alcohol Misuse. This factor 
accounted for 3.3% of the variance and is comprised of the following three items: OQ26, 
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OQ32, and OQ11. VII. Dangerousness. This factor accounted for 3.0% of the variance 
and is comprised of the following three items: OQ44, OQ08, and OQ40. VIII. Conflict. 
This factor accounted for 2.7% of the variance and is comprised of the following three 
items: OQ19, OQ16, and OQ06. IX. Interpersonal Relationship Difficulty. This factor 
accounted for 2.5% of the variance and is comprised of the following two items: OQ01 
and OQ30. 
 The empirically derived nine factor structure just described was next submitted to 
CFA for the purpose of validation using a new sample of 450 cases. The results are 
described below.  
3.4. Validation of Empirically Derived Factor Struc ture (Random Sample 2) 
 Conceptual model. The conceptual model tested is identical to that of the OQ-45.2 
empirically derived nine factor structure described in the previous section. That is, the 
model is specified such that the variables loading on the nine latent constructs are those 
listed as defining the above factors. 
 Statistical model. In this model, there are a total of 42 observed indicator 
variables (OQ01-OQ45 with OQ12, OQ14, and OQ41 removed), 51 unobserved 
variables (9 latent constructs and 42 error terms associated with each OQ-45.2 item), for 
a total of 93 variables in the model. This yields a total of 42 free parameters and 51 fixed 
parameters. Thus, the c2 test for the overall fit of the model is based on 903 sample 
moments, 120 parameters to be estimated, and 783 degrees of freedom. 
 Matrix to be analyzed. Analyses below are based on the covariance matrices of a 
new random sample of 450 baseline OQ-45.2 administrations. The bivariate correlation 
matrix and standard deviations for all OQ-45.2 items are available upon request. 
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 Distribution of data. Univariate estimates of skewness and kurtosis were obtained 
through SPSS Descriptives and are summarized below. The guidelines discussed above 
were applied to determine significance. Similarly to above, the three items relating to 
alcohol misuse were found to depart significantly from univariate normality (PQ11, 
PQ26, and PQ32). Table 13 presents the univariate skewness and kurtosis values for 
these items. 
Multivariate kurtosis was assessed by estimates provided by AMOS based on 
Mardia’s test of multivariate normality (Byrne, 2001; Mardia, 1970). Mardia’s measure 
of multivariate kurtosis was 295.912, with a critical ratio of 51.626. Thus, the sample 
data depart significantly from multivariate normality. 
 
 
Table 13: Non-Normally Distributed OQ-
45.2 Validation Sample Items 
OQ Item Skewness Kurtosis 
OQ11 4.19 21.99 
OQ26 3.17 10.00 
OQ32 3.99 16.47 
OQ11 Transformed -2.59 5.15 
OQ26 Transformed -2.39 4.02 




 Model estimation and fit criteria. Model parameters were estimated through the 
Maximum Likelihood (ML) method. All regression coefficients were significant; and 
accordingly, all variables are retained in this analysis. Visual inspection of the 
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standardized regression coefficients and variances presented in Appendix F revealed than 
no values fell outside of the acceptable range. 
 Because of the excessively kurtotic nature of the data, the bootstrapping 
procedure was employed. See Analysis 1 for a description of this procedure. Appendix F 
contains the parameter estimates obtained through this procedure.  
 Evaluation of model fit. The overall test of model fit indicates that the empirically 
derived nine factor model obtained through PCA is not plausible based on an independent 
sample of data, c2(824, N = 450) = 2332.413, p = .0001, GFI = .787, TLI = .819, and CFI 
= .835. The c2 was also evaluated according to the Bollen-Stine bootstrap method, and 
when using an empirically derived normally distributed sampling distribution was still 
significant, p = .002. However, the fit of this model is a statistically significantly 
improved solution to the three-factor model tested above, ?c2(118) = 740.327, p < .0001. 
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4. OUTCOME QUESTIONNAIRE FACTOR STRUCTURE STABILITY 
 
 This study examined the degree of consistency between the factor structure of the 
OQ-45.2 at the baseline administration and a later administration. This was done so as to 
determine whether the factor structure of the questionnaire remains stable despite elapsed 
time and receipt of treatment intervention or whether the effect of time and intervention is 
such that the underlying constructs measured by the OQ-45.2 are variable. 
4.1. Method 
 4.1.1. Sample 
 The fourth administration of the OQ-45.2 was selected to provide a comparison 
group for addressing this question There were 398 cases with at least four administrations 
of the OQ-45.2. Of these, cases were selected in which there was no more than a twelve 
week interval between the baseline administration and the fourth administration of the 
questionnaire. This yielded 341 cases, or 85.4% of the original sample. The remaining 
cases were excluded from analysis. The average time interval between the baseline and 
fourth administrations was, M = 5.3 weeks (SD = 2.6). 
4.2. Results 
 4.2.1. OQ-45.2 Internal Consistency 
Cronbach’s Coefficient Alpha was computed using SPSS Reliability Analysis to 
assess the internal consistency of the OQ-45.2 at the first and fourth administrations. 
Results for the three theoretically derived subscales of the OQ-45.2 (SD, IR, and SR) are 
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Table14: Internal Consistency Values for the 
OQ-45.2 and Subscale Scores 
1st Administration (N = 450) 
Scale Internal consistency 
Symptoms distress .934 
Interpersonal relationships .805 
Social role .718 
OQ total .939 
4th Administration (N = 341) 
Symptoms distress .943 
Interpersonal relationships .811 
Social role .758 




 4.2.2. Comparison of Baseline and Fourth Administration Factor Structures 
 Distribution of data.  Three variables were found to have significant univariate 
departures from normality in terms of skewness and kurtosis for each sample. These 
variables are the three pertaining to alcohol misuse (PQ11, PQ26, and PQ32). See Table 
15 for the actual skewness and kurtosis values for these variables at each timepoint. 
Mardia’s measure of multivariate kurtosis for the two groups combined was 
338.676, with a critical ratio of 57.744. This indicates that the extent of multivariate non-
normality present in the OQ sample is significant. The transformed variables reduced 
Mardia’s measure of multivariate kurtosis to 301.563 with a critical ratio of 51.416. Thus, 
despite transformation, the multivariate distribution remains significantly non-normal. 
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Table 15: Non-Normally Dis tributed OQ-
45.2 Items 
1st Administration 
OQ Item Skewness Kurtosis 
OQ11  3.98 20.35 
OQ26  3.50 13.92 
OQ32   5.37 32.55 
OQ11 Transformed - 2.57 4.99 
OQ26 Transformed - 2.29 3.61 
OQ32 Transformed - 3.85 13.54 
4th Administration 
OQ11  5.57 36.07 
OQ26  4.68 22.78 
OQ32  4.73 26.47 
OQ11 Transformed - 4.19 16.27 
OQ26 Transformed - 3.38 10.08 




Testing for Invariance. The procedure utilized below allows for comparisons to be 
made with respect to the degree of fit between a specified factor structure for two groups. 
In this case, the first group is comprised of patients who completed baseline 
administrations of the OQ-45.2 and the second group of patients who completed the 
fourth administration. 
  64 
 
The empirically derived nine factor structure detailed above was imposed on the 
fourth administration data to determine the corresponding degree of fit. This was 
accomplished through several steps. First, the models were compared with no equality 
constraints imposed on the parameters, other than those required for the purpose of model 
identification. As recommended by Byrne (2001), multi-group model fit was assessed 
through c2, CFI, and RMSEA. While the first two fit indices were detailed in Study 1, the 
Root Mean Square Error of Approximation (RMSEA) has not been utilized to this point. 
RMSEA provides an indication of the degree of fit between a hypothesized model and 
observed data where values less than .06 represent good fit and values from .08-.10 
represent mediocre fit (Byrne). RMSEA has an associated probability value, which 
should be in excess of .50, as well as confidence intervals. 
In this model the chi-square test was significant, c2 (1648) = 4655.004, p < .0001; 
CFI = .821; and RMSEA = .048, p = .973. This provides the baseline model, the model to 
which subsequent models were compared. 
 The second step involved placing equality constraints on all regression 
coefficients, latent construct variances, and factor covariances. In other words, these 
parameters were statistically forced to be equivalent across the two groups, baseline and 
fourth administration. Model fit was reassessed. The goodness of fit statistics were, c2 
(1726) = 4986.185, p > .05, CFI = .799, and RMSEA = .049, p = .866. The chi-square 
difference (i.e., the difference between this c2 value and that of the baseline model) and 
the associated degrees of freedom difference were tested for significance, Dc2 (78) = 
331.181, p < .05. This indicates that, with all model parameters constrained to equality, 
the two models are not invariant. 
  65 
 
 Third, only the factor loading constraints were retained (i.e., required to be 
statistically equivalent across the two groups). Results revealed that Dc2 (34) = 267.411, 
p > .05, CFI = .800, RMSEA = .049, p = .724. This indicates tha t with the factor loadings 
constrained to equivalency, the two models were not invariant.  
 
 





c2 Df Dc2 Ddf Significance 
Hypothesized 
Model 
Model 1 4655.004 1648 - - - 
All Parameters 
Constrained 




Model 1 4922.415 1682 267.411 34 p < .05 
Factor 1 
Constrained 




Model 1 4888.765 1657 233.761 9 p < .05 
Depression 
Constrained 
Model 1 4882.697 1649 227.693 1 p < .05 
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c2 Df Dc2 Ddf Significance 
Anxiety 
Constrained 
Model 1 4882.622 1649 227.618 1 p < .05 
Role 
Constrained 
Model 1 4883.731 1649 228.727 1 p < .05 
Somatic 
Constrained 
Model 1 4882.335 1649 227.331 1 p < .05 
Love 
Constrained 
Model 1 4884.653 1649 229.649 1 p < .05 
Alcohol 
Constrained 
Model 1 4882.416 1649 227.412 1 p < .05 
Danger 
Constrained 
Model 1 4883.562 1649 228.558 1 p < .05 
Relationships 
Constrained 
Model 1 4882.303 1649 227.229 1 p < .05 
Conflict 
Constrained 




 The next task was to determine the equivalency of the statistical model, which 
involved constraining to equivalency the variances of each of the nine factors. Results 
indicated that the nine factors were not invariant, Dc2 (9) = 233.761, p = .05, CFI = .801, 
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RMSEA = .050, p = .610. Following this, the variance of each of the nine factors was 
constrained sequentially. If the variance of a given factor was determined to be invariant 
across the two groups, this constraint was retained. Otherwise, the constraint was freed 
and freely estimated. Results revealed than none of the variances of the nine factors was 
invariant between the groups. 
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5. DISCUSSION & CONCLUSIONS 
5.1. Discussion 
 Utilizing outpatient mental health samples, the two main goals of this 
investigation were to examine the psychometric properties of the Progress Questionnaire 
and to provide further evidence of the reliability and validity of the Outcome 
Questionnaire. In addition, an overarching aim of this investigation was to determine the 
usability of the PQ for the purpose of monitoring patient progress in treatment and 
conducting patient focused research in outpatient clinical settings. These goals were 
accomplished through three studies, which are summarized below. 
Studies 1 and 2 provided an empirical test of the hypothesis that the PQ and OQ-
45.2 measure three latent constructs that are considered to be important in the assessment 
of treatment change: Symptom Distress, Interpersonal Relations, and Social Role. The 
results of confirmatory tests of this hypothesis in Studies 1 and 2 failed to support the 
presence of this three factor structure. Indeed, the results of the exploratory factor 
analytic procedures revealed that the PQ and OQ-45.2 are comprised of ten and nine 
correlated factors, respectively. In addition, each study examined the reliability of these 
measures and found that the PQ and the OQ-45.2 each possess a desirable degree of 
internal consistency. Study 3 failed to support the hypothesis that the factor structure of 
the OQ-45.2 is invariant across repeated administrations, indicating that the domains 
assessed by the OQ-45.2 vary significantly between the baseline and fourth 
administration. Finally, in Study 1, the PQ was found to be readily implemented in an 
outpatient clinical setting. These findings, as well as the challenges and considerations 
associated with the clinical use of the PQ are discussed further below. 
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Because the three studies just summarized were highly consistent in their 
objectives and outcomes, the major findings and conclusions of each are discussed 
collectively below. The discussion now turns to examination of these findings. The 
discussion that follows includes an evaluation and explanation of the results, explication 
of the contribution of these findings, consideration of the strengths and limitations of 
each study, and recommendations regarding future clinical and research applications of 
the OQ-45.2. 
5.1.1. Major Findings 
 The results of Study 1 establish the psychometric properties of the PQ, and Study 
2 yields further evidence for the operating characteristics of the OQ-45.2 The findings in 
each study are mixed. The theoretically derived three factor structure that each measure is 
purported to possess was not supported. In fact, the fit of the PQ and OQ-45.2 sample 
data to this factor structure was extremely poor, and the addition of the fifteen new items 
to the PQ in Study 1 did not improve this fit.  
This finding is at least partially consistent with the limited existing empirical 
evidence for the factor structure of the OQ-45.2. In a published confirmatory test of the 
theoretically derived factor definition, Mueller et al. (1998) found only weak support for 
the existence of the three latent constructs. However, the present studies depart from this 
finding in that the fit of the three factor solution obtained here was substantially worse 
than that reported by Mueller et al. Overall, then, some question exists as to the validity 
of the theoretical factor structure of the OQ-45.2 based on previous findings and the 
findings of the present stud ies. These results suggest that the latent constructs assessed by 
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the PQ and the OQ-45.2 are not defined by the groupings of items comprising the SD, IR, 
and SR subscales in heterogeneous clinical samples. 
 The PQ and OQ-45.2 were found to possess desirable reliability properties. The 
internal consistency estimates obtained in Studies 1 and 2 are consistent with those 
reported in the existing literature on the OQ-45.2 (e.g., Lambert & Finch, 1999). On each 
measure, the Total Score and SD subscales possess excellent internal consistency, and the 
IR and SR subscales possess acceptable internal consistency. For the OQ-45.2, these 
estimates remained stable across repeated administrations of the questionnaire and with 
time intervals of various lengths between administrations, further solidifying this 
property of the measure. Similarly, the estimates of test-retest reliability for the OQ-45.2 
are consistent with those reported by Lambert and Finch, with the strongest relationships 
between administrations occurring between the Total Score and SD subscale at the two 
timepoints.  
These findings provide further evidence of the excellent reliability of the OQ-45.2 
as a global measure of symptomatology and functioning and the relative weakness of the 
IR and SR subscales in comparison to the Total Score and SD subscale. This, combined 
with previous research findings, suggests that the IR and SR scales are less well defined 
and possess greater heterogeneity of item content that the SD subscale and Total Score. 
Also significant are the test-retest reliability findings. Though consistent with previously 
reported estimates test-retest reliability obtained in an all student sample (Lambert et al., 
1996), these estimates provide evidence of the temporal stability of the OQ-45.2 in an all 
clinical outpatient sample.  
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Because of the excessively poor fit of the three factor structure discussed above, 
exploratory factor analytic procedures were undertaken in Studies 1 and 2 so as to 
provide clues, derived from a strictly empirically based definition of the factor structure, 
as to the constructs that are assessed by these questionnaires. These results provide 
evidence of a more complex factor structure than that originally proposed for the PQ and 
OQ-45.2, with ten or nine correlated factors on the PQ and OQ-45.2, respectively. This 
suggests that both the PQ and OQ-45.2 are comprised of a larger number of smaller, 
more specific factors than intended in their original design. These analyses produced 
desirable relationships among the questionnaire items, indicating that the PQ and OQ-
45.2 are valid measures. 
Due to sample size limitations in Study 1, the empirically derived ten factor 
structure was not validated using an independent sample of data, though this procedure 
was utilized for the OQ-45.2 in Study 2. Although validation of the nine factor structure 
revealed that the model was implausible with an independent sample of data, the model 
did provide significantly improved fit to the three factor model. This provides further 
evidence against the theoretically derived three factor structure and evidence in support 
of nine factors comprising the OQ-45.2. 
 The results of Study 3 indicate that the OQ-45.2 factor structure resulting from 
exploratory procedures using a sample of baseline data does not hold when tested at the 
fourth administration of the questionnaire. One possible explanation for this is that the 
factor structure of the OQ-45.2 varies across time and as a result of treatment 
intervention. In other words, the underlying constructs assessed by this questionnaire may 
not be stable across time and with the amelioration of symptoms and improvement in 
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functioning expected as the result of treatment intervention. In addition, the relatively 
poor fit obtained in Study 2 may be responsible for the poor fit obtained at a later time. 
That is, the factor structure tested at each time-point fit poorly but may have fit poorly in 
different ways. This is an interesting consideration that deserves continued attention once 
the constructs assessed by the OQ-45.2 are more accurately defined. Given the results of 
Studies 1, 2, and 3 just discussed, it is important to address potential explanations for this 
poor fit. This is undertaken below. 
5.1.2. Factors Contributing To Fit 
Specifying the underlying factor structure of the PQ and OQ-45.2 is an important 
task for more than purely theoretical reasons. These questionnaires are designed to 
inform actual clinical practice by providing feedback to the clinician about treatment 
progress. Clinically, then, the instruments’ subscales are used to inform treatment 
planning and clinical decision making. Likewise, in the context of managed care, these 
questionnaires may be utilized to inform decisions regarding the authorization of 
treatment sessions. As a result, it is critical to be confident about the constructs assessed 
by these questionnaires. The findings outlined above call into question the validity of the 
theoretical three factor structure of the PQ and OQ-45.2, suggesting that they are 
comprised of a larger number of factors. Following is a discussion of the possible 
explanations for these findings as well as methods of and considerations in modifying the 
questionnaires so as to improve the definition of the factors. 
There are several possible factors that contribute to the poor fit obtained in the 
analyses discussed above. The most obvious explanation is that of factor 
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misspecification, or the inaccurate definition of the PQ and OQ-45.2 as measures of three 
latent constructs, SD, IR, and SR. Evidence of this position was reviewed above. 
In addition to factor misspecification, there are other potential influences on the 
poor fit of the theoretical factor structure. One possible source of misfit in factor analytic 
studies is the existence of distinct subgroups within the sample whose responses vary 
systematically from those of other groups (Hair et al., 1995). Considering these 
subgroups together as one group, then, serves to obscure the underlying factor structure.  
In this study, there are two main categories of variables around which distinct 
subgroups potentially exist, diagnostic and demographic variables. First, in contrast to 
previous studies on the OQ where approximately 40% of the sample was non-clinical 
(i.e., community and student normals), the samples analyzed here were comprised 
entirely of individuals receiving psychotherapy and or medication management services. 
As a result, the possibility exists that distinct diagnostic subgroups exist within the 
samples of data (e.g., depressive disorders and psychotic disorders). However, the data 
and sample size requirements necessary to test this hypothesis were not available in 
Study 1 or 2. In Study 1, sample size limitations and the limited availability of detailed 
diagnostic data were prohibitive. Likewise, in Study 2, diagnostic data were not available. 
Similarly, the second potential source of differential subgroup responding to the PQ and 
OQ-45.2 items is that of systematic response differences on key demographic variables 
such as age, gender, ethnicity, socio-economic status, etc. 
Modification of the questionnaire’s content is another possible method of 
improving the factor definition of the OQ-45.2, and the results of Studies 1 and 2 identify 
some consistently problematic items. Two items were consistently found to perform 
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poorly based on statistical criteria in the PQ and OQ-45.2 samples. Questions 14 (“I 
work/study too much”) and 41 (“I have trouble falling asleep or staying asleep”) were 
poorly related to the other variables in the analyses. Mueller et al. (1998) also found Item 
14 to perform poorly. Thus, future studies and applications of these questionnaires should 
carefully examine these items for evidence of their utility and/or consider them for 
removal. In addition, recommendations for improving the performance of these items are 
detailed below. 
 The three items related to alcohol misuse, 11, 26, and 32, were also found to be 
problematic in this investigation, as they were significantly non-normally distributed in 
each study (with the exception of Item 26 in Study 1) and poorly related to the other 
questionnaire items. However, these items consistently formed a unique factor in the 
exploratory analyses. Examination of the patients’ responses revealed that these items 
were infrequently endorsed, which raises the issue of the appropriateness of alcohol 
related questions on a questionnaire of symptomatology and functioning designed for an 
outpatient clinical population, as well as the willingness of patients to openly endorse 
alcohol misuse in this setting. 
The alcohol use items were clearly problematic on statistical grounds; however, 
with respect to clinical utility, alcohol use is an important domain to assess. Empirical 
criteria, therefore, should not be the sole determinant of the questionnaire makeup with 
regard to low baserate or highly clinically salient behaviors. Future research, and research 
examining the use of the PQ and OQ-45.2 in a variety of clinical settings and 
populations, should continue to evaluate the functioning and utility of these items, both 
statistically and clinically. 
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5.1.3. Evaluation of Clinical Implementation of the PQ 
 A more general aim of this investigation was to examine the usability of the PQ in 
a patient focused research context. As previously stated, a fundamental goal of patient 
focused research endeavors is the measurement and evaluation of patient functioning 
with minimal interruption to “practice as usual,” referring to the minimal additional 
placement of burden on the provider, office staff, and patient.  
Study 1 provides useful information on the implementation of the PQ. The PQ 
was found to meet the goals just mentioned and was readily implemented into the clinical 
setting with limited challenges. The office staff owned the responsibility for distributing 
and collecting the questionnaires from all new patients. However, because this practice 
was closed shortly after the implementation of the PQ pilot data collection project, the 
provider feedback aspect of this patient focused research endeavor could not be assessed. 
5.1.4. Recommendations for Use of the PQ and OQ-45.2 
 Examination of the overall utility of the PQ (as an alternative measure to the OQ-
45.2) and the OQ-45.2 were additional global aims of this study. The PQ incorporated 
fifteen new items believed by the MBHO to be of particular importance in measuring 
symptomatology and patient progress in treatment. However, these additional items did 
not improve or supplement the reliability and validity of the OQ-45.2. 
The content and /or wording of several of the fifteen new items were problematic 
on theoretical grounds, warranting their removal from the questionnaire and analyses. 
Four of the six variables found to be statistically or theoretically problematic in Study 1 
were new items. More specifically, PQ48, PQ56, and PQ57 presuppose current 
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involvement in mental health treatment (psychotherapy and/or medication management), 
which is inappropriate for a measure administered at the initiation of treatment. 
The amount of variance accounted for in the PQ and OQ-45.2 exploratory 
analyses was consistent, with the nine factor structure of the OQ-45.2 accounting for a 
slightly larger percentage of variance than that of the PQ (62% versus 61%). This 
indicates that the addition of these items did not serve to more fully explain the 
underlying constructs. Likewise, the resulting exploratory factor structures were similarly 
defined, again suggesting that the new items did not improve the definition of the latent 
constructs. Based on the findings just described, further use of the PQ is not 
recommended. 
Also of particular importance, with respect to the clinical use of these measures, 
was the amount of missing data present in the completed questionnaires. The patterns of 
missing data suggest that questionnaire completion rates would likely be improved by 
making modifications to the questionnaire’s instructions and response choices. That is, 
the missing data revealed that the items most frequently skipped are those that are not 
applicable to certain patients (e.g., “I feel unhappy in my marriage/significant 
relationship”), as opposed to those which all patients are able to answer (e.g., “I like 
myself”). The instructions and response options on the OQ-45.2 should be reworded to 
plainly reflect that a response choice of zero indicates “Does Not Apply” and/or “Not At 
All.” The response choice of “0=Never” should be changed to “0=Never/Not 
Applicable.” 
Questionnaire completion rates would be improved by respecifying the question 
content of items that are potentially “Not Applicable.” For instance, “I feel stressed at 
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work/school” (OQ04) should be reworded to “I feel stressed in my main role (work, 
school, home, or volunteer).” Wording that explicitly reflects the variety of activities 
comprising social role functioning (i.e., work, school, home, volunteer) should be applied 
to the remaining social role items (OQ12, OQ14, OQ28, OQ32, OQ38, OQ39, and 
OQ44). By modifying these items, they become applicable to virtually all respondents. 
Also related to problematic questions, “I have trouble falling asleep or staying 
asleep” (OQ-41) was repeatedly found to correlate poorly with the other OQ-45.2 items. 
However, some concern is noted in removing this item from the questionnaire based on 
the clinical observation that sleep disturbance is a frequently occurring symptom, relevant 
target of intervention, and indicator of treatment response when improving. The 
performance of this item would likely be improved through the modification of its 
content and the addition of related items. For example, changing OQ41 to “I have 
difficulty falling asleep” and adding “I wake frequently during the night” and “I wake up 
early and am unable to fall back to sleep” so as to better define a sleep factor. 
On a side note, with respect to missing data, a promising solution to the problem 
is the increasing availability and application of computer-based assessment procedures. 
This includes local and web-based assessment packages as well as the use of handheld 
devices. Computer-based data collection methods ensure complete responses to all items 
by forcing response choices. 
A number of recommendations regarding the future use of the OQ-45.2 can be 
made based on the results of this investigation. When utilized in a patient- focused 
research endeavor, the clinician receives a feedback report detailing the patient’s scores, 
endorsement of critical items, and treatment trajectory. Clinicians should continue to use 
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and be confident in the OQ-45.2 total score as a global indicator of symptomatology and 
functioning. However, the three theoretical subscales should not be used for the purpose 
of making treatment related decisions, as support was not found for the existence of these 
factors. Alternatively, the 9 factor structure detailed in Study 2 should be implemented. 
There are two main benefits of this approach. First, the nine factor structure enjoys 
statistically improved fit from the three factor structure, that is, it provides a more 
accurate definition of the constructs assessed by the OQ-45.2. Second, the nine factors 
are more specific and inherently more meaningful clinically than the three factor model. 
Finally, the clinician is encouraged to examine the individual item endorsement of 
treatment-relevant questions.  
The decision to utilize the OQ-45.2 as an outcomes measurement system is 
largely dependent upon the goals of the clinician, practice, and/or research endeavor. 
Questionnaires designed for patient- focused research are not best suited for traditional 
effectiveness and efficacy research designs that allow for the use of multiple assessment 
instruments and varying degrees of modification to clinical practice during data 
collection. Likewise, these instruments are not best suited for diagnosis-specific 
assessment purposes. That is, if the clinical and/or research goal is to provide an accurate 
measure of the symptomatology associated with a particular diagnosis (e.g., depression), 
well-established and psychometrically sound diagnosis-specific assessment instruments 
(e.g., BDI-II) are a more appropriate choice. 
However, if the goal of the clinician, practice, and/or research endeavor is 
ongoing evaluation of patient progress in treatment (in contrast to an episode of data 
collection for the purpose of answering a specific research question), coupled with the 
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provision of feedback to the clinician for the purpose of treatment modification, the OQ-
45.2 is an excellent choice. More specifically, a substantial body of research exists 
supporting the internal consistency, test-retest reliability, and, with this investigation, the 
factor structure of the instrument. In addition, the OQ-45.2 possesses items related to 
interpersonal functioning and primary role functioning, an improvement upon existing 
global measures that are limited in scope to the assessment of symptoms. Finally, the 
OQ-45.2 has the benefit of providing an individual expected treatment response that can 
be utilized to adjust treatment and evaluated the effectiveness of interventions. This is not 
meant to suggest that the OQ-45.2 is without limitations. Rather, it enjoys empirical 
support and is a positive step toward the inclusion of measurement/evaluation as a 
standard component of routine clinical practice 
 With respect to future questionnaire modification, a seemingly beneficial feature 
of many outcome measurement systems similar to the OQ-45.2 is the flexibility to tailor 
questionnaire item content to specific clinical settings and domains of inquiry. However, 
as evidenced in Study 1, this practice should be employed extremely judiciously, and any 
such questionnaire modifications should be made with sound theoretical justification. 
Because questionnaire modification weakens existing confidence in an instrument’s 
psychometric properties, modifications should be submitted to empirical and statistical 
scrutiny, as in this investigation, so as to establish the psychometric properties of the new 
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5.1.5. Strengths and Limitations  
A notable strength of this investigation is that the findings detailed above were 
obtained in an entirely clinical sample. As discussed previously, much of the existing 
literature on the psychometric properties of the OQ-45.2 were obtained in “normal” 
populations (e.g., Lambert & Finch, 1999). Thus, Study 2 provides the first known 
reliability estimates of the measure that are based on an entirely outpatient clinical 
sample. Likewise, if the PQ is utilized further, the results of Study 1 establish the internal 
consistency and validity characteristics of the PQ in an outpatient mental health sample, 
the population for which it is intended. The same is also true of the principle components 
analysis findings, which represent the first published accounts of exploratory factor 
analytic procedures describing the underlying constructs of the OQ-45.2. 
An additional strength, in contrast to many studies occurring in the social 
sciences, is that the sample sizes of Studies 1 and 2 were adequate and even desirable. 
That is, the PQ sample was of sufficient size to rule out sample size limitations as a 
primary explanation for the poor confirmatory factor analysis findings. Likewise, the 
extremely large set of data available on the OQ-45.2 permitted the validation of 
exploratory findings on a separate sample as well as analysis of data across multiple time 
points. This further solidifies the existing knowledge of the operating characteristics of 
the OQ-45.2.  
An important limitation of these studies is the presence of incomplete data on key 
demographic and diagnostic variables. Given the poorly fitting factor structure, the 
availability of such data, with a correspondingly large sample size, would permit more 
precise investigation of the factor structure of the PQ and OQ-45.2. Unfortunately, the 
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premature termination of the PQ data collection prevented the attainment of samples of 
adequate size for such analysis. In addition, the large number of “Diagnosis Deferred” 
diagnoses in Study 1 was problematic, as was the missing demographic data, as it 
prevented further evaluation of this hypothesis. These are important areas for 
consideration in future studies of the OQ-45.2. 
5.1.6. Future Directions  
 Future research should continue to be conducted on the OQ-45.2 in various 
clinical settings and utilizing diverse clinical populations. As in this investigation, 
psychometric studies of frequently employed assessment instruments, particularly those 
providing data used to make decisions affecting patient care, should be routinely 
conducted with each new use of the questionnaire. A significant body of research is 
amassing on the OQ-45.2, and these research endeavors should continue. Given the 
increasingly widespread use of the OQ-45.2, and the proliferation of systems like it, the 
opportunity exists to convincingly establish this, and other, instrument’s psychometric 
properties while contributing significantly to the understanding of changes that occur 
through psychotherapy. 
A fundamental question that remains involves the underlying factor structure of 
the OQ-45.2. The results of this study indicate that the OQ-45.2 more accurately 
measures nine factors despite limited support for the three factor structure. This is a 
critical issue that should continue to be addressed, taking into consideration the possible 
explanations discussed above for the problematic fit achieved to date. 
Future research should utilize both exploratory and confirmatory factor analytic 
procedures so as to more precisely specify and define the underlying factor structure of 
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the OQ-45.2. Likewise, item response theory, and analyses occurring at item level, 
should be applied so as to better illuminate the functioning and performance of individual 
items comprising the OQ-45.2. The lack of such investigations in the literature to date is 
striking provided the number of studies utilizing this questionnaire and the massive 
amounts of data that have been collected. This may be the result of inadequate 
investigation of the factor structure or the lack of desirable findings resulting in a limited 
number of publications. Regardless of the cause, this is an important issue given the 
current reliance of the OQ-45.2 and the provider feedback on the three subscales. In 
addition to future factor analytic studies, these studies should consider the effect of 
diagnostic and demographic subgroups on factor definition. Though the answers to these 
questions, and a clearly supported factor structure, remain unclear, the performance of the 
OQ-45.2 as a reliable and valid global measure of symptomatology and functioning is 
more well- founded. This is an important point, as the findings to date do not suggest that 
the OQ-45.2 is not valid; rather, they indicated that the subscales are potentially in need 
of redefinition. 
The questions and issues facing the OQ-45.2 just discussed ultimately reduce to 
the issue of construct validity. Much more confirmatory and exploratory factor analytic 
work incorporating the recommendations made above needs to be done, but a 
fundamental question facing the OQ-45.2 is whether the theory underlying its 
construction (i.e., the constructs important in measuring psychotherapy change are 
symptom distress, interpersonal relationships, and social role functioning) is in need of 
respecification. 
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5.2. Conclusion 
In conclusion, this investigation provides further evidence of the psychometric 
properties of the OQ-45.2 while establishing these properties for the PQ. Such 
instruments and outcomes measurement systems are being increasingly integrated into 
routine clinical practice in the context of patient- focused research endeavors. This is an 
exciting direction for the field, as it seems to provide an ideal marriage of research and 
clinical practice. The result is an increased understanding of improvements achieved 
through psychotherapy and medication-based treatment interventions through the clinical 
implementation of an ongoing treatment response information system. Ideally, this 
combination of research and clinical practice will continue to proliferate, to the benefit of 
patients and the current understanding of mental illness and its treatment. 
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INSTRUCTIONS: Looking back over the last week, including 
today, help us understand how you have been feeling. Read 
each item carefully and circle the number best describes your 
current situation. For this questionnaire, work is defined as 
employment, school, housework, volunteer work and so 
forth. 
 0 1 2 3 4  1. I get along well with others.  
 
0 1 2 3 4  2. I tire quickly. 
 
0 1 2 3 4  3. I feel no interest in things.  
 
0 1 2 3 4  4. I feel stressed at work/school. 
 
0 1 2 3 4  5. I blame myself for things.  
 
0 1 2 3 4  6. I feel irritated. 
0 1 2 3 4  7. I feel unhappy in my marriage/significant relationship.  
0 1 2 3 4  8. I have thoughts of ending my life. 
 
0 1 2 3 4  9. I feel weak.  
0 1 2 3 4  10.  I feel fearful. 
0 1 2 3 4 
 11.  After heavy drinking, I need a drink the next morning to get going 
(If you do not drink, mark “never”).  
0 1 2 3 4  12.  I find my work/school satisfying. 
0 1 2 3 4  13.  I am a happy person.  
0 1 2 3 4  14.  I work/study too much. 
0 1 2 3 4  15.  I feel worthless. 
0 1 2 3 4  16.  I am concerned about family troubles. 
0 1 2 3 4  17.  I have an unfulfilling sex life. 
0 1 2 3 4  18.  I feel lonely. 
0 1 2 3 4  19.  I have frequent arguments. 
0 1 2 3 4  20.  I feel loved and wanted. 
0 1 2 3 4  21.  I enjoy my spare time. 
0 1 2 3 4  22.  I have difficulty concentrating. 
0 1 2 3 4  23.  I feel hopeless about the future. 
0 1 2 3 4  24.  I like myself. 
0 1 2 3 4  25.  Disturbing thoughts come into my mind that I cannot get rid of. 
0 1 2 3 4 
 26.  I feel annoyed by people who criticize my drinking (or drug use) (if 
not applicable, mark “never”). 
0 1 2 3 4  27.  I have an upset stomach. 
0 1 2 3 4  28.  I am not working/studying as well as I used to. 
0 1 2 3 4  29.  My heart pounds too much. 


































INSTRUCTIONS: Looking back over the last week, including 
today, help us understand how you have been feeling. Read 
each item carefully and circle the number best describes your 
current situation. For this questionnaire, work is defined as 
employment, school, housework, volunteer work and so 
forth. 
 0 1 2 3 4  30.  I have trouble getting along with friends and close acquaintances. 
0 1 2 3 4  31.  I am satisfied with my life. 
0 1 2 3 4 
 32.  I have trouble at work/school because of my drinking or drug use  
(if not applicable, mark “never”). 
0 1 2 3 4  33.  I feel that something bad is going to happen. 
0 1 2 3 4  34.  I have sore muscles. 
0 1 2 3 4 
 35.  I feel afraid of open spaces, of driving, or being on buses, 
subways, and so forth. 
0 1 2 3 4  36.  I feel nervous. 
0 1 2 3 4  37.  I feel my love relationships are full and complete. 
0 1 2 3 4  38.  I feel that I am not doing well at work/school. 
0 1 2 3 4  39.  I have too many disagreements at work/school. 
0 1 2 3 4  40.  I feel something is wrong with my mind. 
0 1 2 3 4  41.  I have trouble falling asleep or staying asleep. 
0 1 2 3 4  42.  I feel blue. 
0 1 2 3 4  43.  I am satisfied with my relationships with others. 
0 1 2 3 4  44.  I feel angry enough at work/school to do something I might regret. 
0 1 2 3 4  45.  I have headaches. 
0 1 2 3 4  46.  I have episodes where I do things to hurt myself physically. 
0 1 2 3 4  47.  I worry about my physical health problems. 
0 1 2 3 4  48.  I have crises where I call my therapist or psychiatrist. 
0 1 2 3 4  49.  I have thoughts of hurting other people. 
0 1 2 3 4 
 50.  I have days where I am less productive at work because of 
emotional distress. 
0 1 2 3 4  51.  I have a poor appetite or I find myself overeating. 
0 1 2 3 4 
 52.  I have been moving or speaking so slowly that other people have 
noticed. 
0 1 2 3 4  53.  I have been so fidgety or restless that other people have noticed. 
0 1 2 3 4 
 54.  I have had periods that lasted more than a few days where I felt 
speeded up, had lots of energy, and didn’t need sleep. 
0 1 2 3 4 
 55.  I have excessive worry (that I can’t control) occurring more days 
than not, about a number of events or activities. 
0 1 2 3 4 
 56.  I am taking medication for depression, anxiety, or other mental 
health problems. 
0 1 2 3 4  57.  I am taking my medication exactly as prescribed. 
0 1 2 3 4 
 58.  I see and hear things that other people do not see or hear and 
that really might not be there. 


































INSTRUCTIONS: Looking back over the last week, including 
today, help us understand how you have been feeling. Read 
each item carefully and circle the number best describes your 
current situation. For this questionnaire, work is defined as 
employment, school, housework, volunteer work and so 
forth. 
 0 1 2 3 4  59.  I have panic or anxiety attacks that come suddenly out of the blue. 
0 1 2 3 4 
 60.  I have upsetting thoughts, nightmares, or flashbacks about a 
stressful event that I experienced. 
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Table B1: PQ CFA Unstandardized Regression Weights 
   Estimate S.E. C.R. P 
pq02 ¬ PQ-SD 1    
pq03 ¬ PQ-SD 1.376 0.176 7.816 .0001 
pq05 ¬ PQ-SD 1.284 0.172 7.453 .0001 
pq06 ¬ PQ-SD 1.218 0.158 7.697 .0001 
pq08 ¬ PQ-SD 1.093 0.163 6.723 .0001 
pq09 ¬ PQ-SD 1.715 0.206 8.342 .0001 
pq10 ¬ PQ-SD 1.537 0.2 7.7 .0001 
pq11t ¬ PQ-SD -0.07 0.026 -2.664 .008 
pq13 ¬ PQ-SD 1.102 0.157 7.008 .0001 
pq15 ¬ PQ-SD 1.768 0.21 8.434 .0001 
pq22 ¬ PQ-SD 1.139 0.158 7.223 .0001 
pq23 ¬ PQ-SD 1.707 0.209 8.18 .0001 
pq24 ¬ PQ-SD 1.307 0.176 7.405 .0001 
pq25 ¬ PQ-SD 1.571 0.2 7.851 .0001 
pq27 ¬ PQ-SD 0.992 0.154 6.449 .0001 
pq29 ¬ PQ-SD 1.256 0.18 6.963 .0001 
pq31 ¬ PQ-SD 1.381 0.186 7.423 .0001 
pq33 ¬ PQ-SD 1.614 0.201 8.032 .0001 
pq34 ¬ PQ-SD 0.871 0.157 5.557 .0001 
  93 
 
Table B1: PQ CFA Unstandardized Regression Weights 
(continued) 
   Estimate S.E. C.R. P 
pq35 ¬ PQ-SD 0.866 0.163 5.318 .0001 
pq36 ¬ PQ-SD 1.543 0.194 7.945 .0001 
pq40 ¬ PQ-SD 1.743 0.217 8.024 .0001 
pq41 ¬ PQ-SD 1.488 0.203 7.343 .0001 
pq42 ¬ PQ-SD 1.647 0.196 8.402 .0001 
pq45 ¬ PQ-SD 0.699 0.147 4.759 .0001 
pq46 ¬ PQ-SD 0.606 0.114 5.303 .0001 
pq47 ¬ PQ-SD 0.981 0.172 5.698 .0001 
pq49 ¬ PQ-SD 0.536 0.12 4.472 .0001 
pq51 ¬ PQ-SD 1.252 0.182 6.882 .0001 
pq52 ¬ PQ-SD 1.001 0.16 6.255 .0001 
pq53 ¬ PQ-SD 1.338 0.195 6.875 .0001 
pq54 ¬ PQ-SD 0.777 0.146 5.314 .0001 
pq55 ¬ PQ-SD 1.864 0.231 8.062 .0001 
pq58 ¬ PQ-SD 0.398 0.111 3.573 .0001 
pq59 ¬ PQ-SD 1.442 0.198 7.289 .0001 
pq60 ¬ PQ-SD 1.542 0.21 7.351 .0001 
pq01 ¬ PQ-IR 1    
pq07 ¬ PQ-IR 2.116 0.416 5.082 .0001 
pq16 ¬ PQ-IR 1.11 0.278 3.989 .0001 
pq17 ¬ PQ-IR 1.784 0.377 4.735 .0001 
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Table B1: PQ CFA Unstandardized Regression Weights 
(continued) 
   Estimate S.E. C.R. P 
pq18 ¬ PQ-IR 2.6 0.436 5.959 .0001 
pq19 ¬ PQ-IR 1.528 0.31 4.927 .0001 
pq20 ¬ PQ-IR 2.633 0.438 6.012 .0001 
pq26 ¬ PQ-IR 0.866 0.235 3.687 .0001 
pq30 ¬ PQ-IR 1.942 0.338 5.745 .0001 
pq37 ¬ PQ-IR 2.6 0.454 5.722 .0001 
pq43 ¬ PQ-IR 2.252 0.383 5.873 .0001 
pq04 ¬ PQ-SR 1    
pq12 ¬ PQ-SR 0.634 0.099 6.396 .0001 
pq14 ¬ PQ-SR 0.307 0.092 3.346 .001 
pq21 ¬ PQ-SR 0.701 0.099 7.101 .0001 
pq28 ¬ PQ-SR 0.945 0.108 8.741 .0001 
pq32t ¬ PQ-SR -0.053 0.018 -2.922 .003 
pq38 ¬ PQ-SR 0.881 0.11 8.011 .0001 
pq39 ¬ PQ-SR 0.666 0.09 7.368 .0001 
pq44 ¬ PQ-SR 0.753 0.096 7.872 .0001 
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Table B2: Standardized Regression 
Weights 
   Estimate 
pq02 ¬ PQ-SD  .494 
pq03 ¬ PQ-SD  .67 
pq05 ¬ PQ-SD  .613 
pq06 ¬ PQ-SD  .651 
pq08 ¬ PQ-SD  .516 
pq09 ¬ PQ-SD  .768 
pq10 ¬ PQ-SD  .651 
pq11t ¬ PQ-SD - .168 
pq13 ¬ PQ-SD  .552 
pq15 ¬ PQ-SD  .787 
pq22 ¬ PQ-SD  .58 
pq23 ¬ PQ-SD  .735 
pq24 ¬ PQ-SD  .606 
pq25 ¬ PQ-SD  .676 
pq27 ¬ PQ-SD  .484 
pq29 ¬ PQ-SD  .546 
pq31 ¬ PQ-SD  .609 
pq33 ¬ PQ-SD  .708 
pq34 ¬ PQ-SD  .393 
pq35 ¬ PQ-SD  .371 
pq36 ¬ PQ-SD  .692 
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Table B2: Standardized Regression 
Weights (continued) 
   Estimate 
pq40 ¬ PQ-SD  .706 
pq41 ¬ PQ-SD  .597 
pq42 ¬ PQ-SD  .78 
pq45 ¬ PQ-SD  .323 
pq46 ¬ PQ-SD  .37 
pq47 ¬ PQ-SD  .407 
pq49 ¬ PQ-SD  .3 
pq51 ¬ PQ-SD  .536 
pq52 ¬ PQ-SD  .463 
pq53 ¬ PQ-SD  .535 
pq54 ¬ PQ-SD  .371 
pq55 ¬ PQ-SD  .713 
pq58 ¬ PQ-SD  .232 
pq59 ¬ PQ-SD  .59 
pq60 ¬ PQ-SD  .598 
pq01 ¬ PQ-IR  .383 
pq07 ¬ PQ-IR  .471 
pq16 ¬ PQ-IR  .311 
pq17 ¬ PQ-IR  .411 
pq18 ¬ PQ-IR  .72 
pq19 ¬ PQ-IR  .443 
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Table B2: Standardized Regression 
Weights (continued) 
   Estimate 
pq20 ¬ PQ-IR  .744 
pq26 ¬ PQ-IR  .278 
pq30 ¬ PQ-IR  .638 
pq37 ¬ PQ-IR  .631 
pq43 ¬ PQ-IR  .685 
pq04 ¬ PQ-SR  .653 
pq12 ¬ PQ-SR  .438 
pq14 ¬ PQ-SR  .222 
pq21 ¬ PQ-SR  .492 
pq28 ¬ PQ-SR  .627 
pq32t ¬ PQ-SR - .193 
pq38 ¬ PQ-SR  .565 
pq39 ¬ PQ-SR  .513 
pq44 ¬ PQ-SR  .554 




Table B3: PQ Subscale Covariances 
   Estimate S.E. C.R. P 
PQ-SD « PQ-IR .132 0.028 4.649 .0001
PQ-SD « PQ-SR .318 0.055 5.783 .0001
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Table B3: PQ Subscale Covariances (continued) 
   Estimate S.E. C.R. P 




Table B4: PQ Subscale Correlations 
   Estimate 
PQ-SD « PQ-IR .761 
PQ-SD « PQ-SR .694 




Table B5: PQ CFA Variances 
 Estimate S.E. C.R. P 
PQ-SD 0.285 0.066 4.299 .0001 
PQ-IR 0.105 0.034 3.106 .002 
PQ-SR 0.74 0.131 5.651 .0001 
e02 0.884 0.076 11.598 .0001 
e03 0.661 0.058 11.336 .0001 
e05 0.778 0.068 11.449 .0001 
e06 0.576 0.051 11.379 .0001 
e08 0.937 0.081 11.576 .0001 
e09 0.583 0.053 11.007 .0001 
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Table B5: PQ CFA Variances (continued) 
 Estimate S.E. C.R. P 
e10 0.913 0.08 11.378 .0001 
e11 0.048 0.004 11.753 .0001 
e13 0.791 0.069 11.537 .0001 
e15 0.545 0.05 10.904 .0001 
e22 0.727 0.063 11.499 .0001 
e23 0.704 0.063 11.144 .0001 
e24 0.837 0.073 11.461 .0001 
e25 0.835 0.074 11.322 .0001 
e27 0.913 0.079 11.606 .0001 
e29 1.059 0.092 11.544 .0001 
e31 0.921 0.08 11.456 .0001 
e33 0.739 0.066 11.236 .0001 
e34 1.181 0.101 11.672 .0001 
e35 1.337 0.114 11.684 .0001 
e36 0.736 0.065 11.28 .0001 
e40 0.869 0.077 11.241 .0001 
e41 1.137 0.099 11.475 .0001 
e42 0.496 0.045 10.943 .0001 
e45 1.194 0.102 11.707 .0001 
e46 0.661 0.057 11.685 .0001 
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Table B5: PQ CFA Variances (continued) 
 Estimate S.E. C.R. P 
e47 1.383 0.119 11.664 .0001 
e49 0.828 0.071 11.716 .0001 
e51 1.109 0.096 11.555 .0001 
e52 1.044 0.09 11.624 .0001 
e53 1.271 0.11 11.556 .0001 
e54 1.08 0.092 11.684 .0001 
e55 0.954 0.085 11.219 .0001 
e58 0.794 0.068 11.739 .0001 
e59 1.111 0.097 11.486 .0001 
e60 1.214 0.106 11.473 .0001 
e01 0.612 0.053 11.484 .0001 
e07 1.649 0.146 11.295 .0001 
e16 1.214 0.105 11.592 .0001 
e17 1.65 0.144 11.432 .0001 
e18 0.661 0.066 9.966 .0001 
e19 1.007 0.089 11.364 .0001 
e20 0.587 0.061 9.684 .0001 
e26 0.942 0.081 11.63 .0001 
e30 0.577 0.054 10.621 .0001 
e37 1.075 0.101 10.665 .0001 
e43 0.604 0.059 10.292 .0001 
  101 
 
Table B5: PQ CFA Variances (continued) 
 Estimate S.E. C.R. P 
e04 0.996 0.099 10.105 .0001 
e12 1.253 0.111 11.24 .0001 
e14 1.349 0.116 11.654 .0001 
e21 1.136 0.103 11.057 .0001 
e28 1.021 0.099 10.32 .0001 
e32 0.053 0.005 11.683 .0001 
e38 1.225 0.114 10.723 .0001 
e39 0.918 0.084 10.973 .0001 
e44 0.949 0.088 10.783 .0001 
e50 0.748 0.078 9.608 .0001 
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Table C1: PQ Pattern Matrix 
 1 2 3 4 5 6 7 8 9 10 
PQ25 .792 -.143 -.084 .075 -.022 -.072 -.13 .246 .002 .115 
PQ23 .749 .204 -.091 .071 -.106 -.053 .074 .038 -.126 .015 
PQ08 .721 .011 -.173 -.143 -.084 .2 .019 .259 -.015 -.092 
PQ05 .702 -.055 -.035 -.103 .086 -.01 .203 -.184 .129 -.034 
PQ40 .689 .016 -.194 .034 .171 .004 -.084 .16 .086 .136 
PQ42 .684 .02 .099 .024 .127 .044 -.034 .039 -.108 -.007 
PQ15 .682 .15 -.127 .135 .049 .058 .093 -.05 -.005 .039 
PQ33 .645 -.048 -.081 .33 -.058 .002 -.023 .087 .054 -.103 
PQ06 .613 .114 .19 -.201 -.075 -.143 -.021 .064 .28 .086 
PQ21 .584 .328 .006 -.175 -.003 -.103 -.09 .034 -.032 .123 
PQ09 .538 .056 .21 .147 -.014 .007 .107 -.099 -.125 .149 
PQ55 .537 -.1 .115 .306 .018 -.051 .016 .134 -.049 -.066 
PQ24 .516 .422 -.086 -.018 -.039 .052 -.005 .003 -.064 -.02 
PQ22 .516 .05 .031 -.013 .168 -.109 -.184 -.084 .039 .292 
PQ03 .503 .196 .065 .006 .098 -.017 -.015 -.209 .002 .259 
PQ18 .406 .207 -.045 .031 .203 .046 .298 -.097 .131 -.071 
PQ60 .353 .012 .219 .282 -.06 .096 -.115 -.067 .219 -.197 
PQ01 -.157 .741 -.021 .169 -.191 -.039 -.256 -.059 .287 .117 
PQ13 .239 .667 .133 .049 -.074 -.01 -.205 .069 -.181 -.033 
  103 
 
Table C1: PQ Pattern Matrix (continued) 
 1 2 3 4 5 6 7 8 9 10 
PQ43 .154 .624 -.129 .03 -.077 .086 .135 .065 .114 .126 
PQ37 .108 .607 -.044 .013 -.011 -.145 .299 .126 -.036 -.102 
PQ20 .123 .552 -.025 .021 .13 .084 .222 .009 .05 -.083 
PQ30 -.127 .546 -.044 .236 .045 .137 .064 -.036 .377 .165 
PQ31 .438 .536 -.035 -.052 -.081 -.003 .16 .101 -.132 -.053 
PQ12 -.132 .515 .29 -.168 .309 -.03 -.075 .094 -.183 -.221 
PQ45 -.079 .022 .833 -.272 -.003 .029 -.065 .03 .181 -.017 
PQ27 -.075 -.035 .75 -.026 -.062 .092 .143 .2 .025 .182 
PQ34 -.222 .032 .679 .219 -.23 .023 .194 .111 .038 .154 
PQ02 .11 .085 .537 .02 -.009 .061 .001 -.202 -.106 .261 
PQ29 .207 -.106 .425 .299 -.038 .059 -.038 .046 .02 -.127 
PQ51 .39 -.124 .418 -.128 .123 .055 -.054 -.186 .079 .13 
PQ35 -.093 .105 -.244 .821 -.031 -.055 .15 -.078 .083 .137 
PQ59 .211 .072 .055 .632 .038 -.008 -.259 -.093 .024 -.004 
PQ36 .188 .128 .161 .565 .084 -.04 .051 -.075 -.131 .01 
PQ10 .418 -.052 -.09 .541 .075 -.035 .16 -.129 -.123 .007 
PQ47 -.113 -.108 .388 .403 -.02 -.039 .097 .154 -.175 .342 
PQ38 .141 -.135 -.33 .049 .915 .104 -.072 -.107 . .047 
PQ28 .006 -.053 .034 -.015 .681 .049 .099 .174 -.127 .379 
PQ04 .057 .179 .156 .03 .584 -.068 -.008 -.044 -.015 -.299 
PQ50 .231 -.124 .12 -.074 .581 .018 .059 .148 .022 .074 
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Table C1: PQ Pattern Matrix (continued) 
 1 2 3 4 5 6 7 8 9 10 
PQ39 -.305 .155 .033 .055 .453 -.075 .026 .335 .376 -.04 
PQ11 -.122 -.02 .144 .09 .092 .852 -.07 -.176 -.009 -.096 
PQ32 .101 -.053 .023 -.146 .032 .837 .066 -.052 -.04 .066 
PQ26 -.13 .081 .072 -.078 .054 .755 .078 .073 .059 .023 
PQ17 -.172 .18 -.018 .147 .068 .091 .741 -.019 .02 .05 
PQ07 .236 -.023 .186 -.143 -.087 .006 .601 -.035 .299 -.141 
PQ16 .246 -.212 .153 .133 -.091 -.158 .514 -.118 .272 -.037 
PQ49 .105 .098 .144 -.182 -.04 -.083 -.043 .761 -.002 .21 
PQ44 .025 .097 .008 .059 .246 -.064 -.031 .629 .16 -.018 
PQ46 .305 .075 -.003 -.01 -.242 .367 -.127 .411 .046 .039 
PQ19 .046 .08 .148 -.114 -.121 -.013 .274 -.014 .78 .05 
PQ54 .062 -.172 -.024 .152 .172 .047 .019 .233 .538 .111 
PQ52 .128 .007 .146 .108 -.047 .013 .005 .169 .037 .628 




Table C2: PQ Structure Matrix 
 1 2 3 4 5 6 7 8 9 10 
PQ15 .799 .466 .347 .453 .354 .234 .31 .131 .16 .187 
PQ42 .786 .366 .495 .428 .432 .194 .205 .178 .118 .123 
PQ23 .771 .467 .312 .382 .222 .135 .318 .146 .035 .157 
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Table C2: PQ Structure Matrix (continued) 
 1 2 3 4 5 6 7 8 9 10 
PQ09 .745 .345 .549 .481 .317 .124 .333 . .011 .3 
PQ25 .724 .207 .317 .433 .253 .167 .06 .312 .192 .169 
PQ40 .724 .373 .273 .38 .412 .235 .1 .293 .28 .204 
PQ33 .722 .251 .36 .601 .249 .208 .136 .267 .241 -.007 
PQ55 .701 .211 .499 .613 .332 .132 .19 .263 .142 .022 
PQ05 .692 .265 .335 .223 .326 .068 .352 -.068 .192 .091 
PQ06 .682 .414 .467 .209 .289 .046 .108 .134 .413 .14 
PQ03 .662 .44 .414 .298 .359 .086 .194 -.111 .119 .396 
PQ18 .658 .496 .358 .315 .467 .166 .436 .098 .234 .051 
PQ24 .621 .601 .241 .245 .246 .211 .202 .16 .119 .11 
PQ21 .614 .531 .295 .142 .275 .059 .123 .093 .131 .219 
PQ08 .605 .305 .117 .197 .142 .387 .171 .393 .166 -.018 
PQ22 .582 .301 .367 .271 .371 .018 . -.037 .174 .369 
PQ60 .576 .242 .51 .541 .26 .22 -.032 .164 .415 -.112 
PQ43 .446 .727 .131 .193 .192 .281 .25 .233 .225 .212 
PQ13 .494 .721 .346 .269 .245 .152 .019 .212 .077 .082 
PQ20 .483 .698 .264 .224 .389 .222 .352 .213 .191 .023 
PQ31 .612 .696 .255 .216 .241 .174 .374 .23 .032 .077 
PQ37 .393 .674 .179 .15 .25 .013 .426 .223 .049 -.026 
PQ30 .363 .652 .233 .343 .297 .322 .086 .209 .483 .214 
PQ01 .148 .641 .094 .157 .03 .119 -.231 .098 .404 .142 
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Table C2: PQ Structure Matrix (continued) 
 1 2 3 4 5 6 7 8 9 10 
PQ12 .19 .539 .345 .014 .457 .002 .058 .19 .028 -.171 
PQ27 .379 .193 .718 .334 .265 .181 .206 .225 .138 .207 
PQ45 .255 .176 .708 .084 .281 .034 -.045 .062 .309 -.009 
PQ34 .26 .143 .622 .417 .085 .099 .214 .135 .086 .181 
PQ29 .5 .118 .614 .566 .266 .155 .058 .19 .201 -.058 
PQ02 .424 .238 .606 .283 .245 .062 .15 -.167 -.016 .374 
PQ51 .542 .153 .591 .236 .363 .074 .078 -.116 .195 .223 
PQ59 .507 .221 .435 .735 .281 .137 -.128 .112 .23 .084 
PQ36 .596 .32 .541 .727 .375 .089 .23 .095 .036 .136 
PQ35 .265 .155 .11 .688 .098 .091 .176 .077 .089 .19 
PQ10 .628 .182 .36 .673 .296 .08 .334 .021 -.025 .143 
PQ47 .282 .035 .482 .532 .175 .064 .187 .134 -.117 .37 
PQ38 .291 .133 .1 .177 .784 .116 .032 .053 .137 .083 
PQ04 .383 .369 .449 .249 .711 -.036 .115 .128 .19 -.237 
PQ28 .358 .249 .328 .236 .708 .147 .238 .209 -.007 .396 
PQ50 .492 .23 .443 .268 .702 .121 .185 .243 .189 .101 
PQ39 .104 .312 .215 .18 .536 .093 -.038 .461 .496 -.137 
PQ32 .215 .132 .044 .06 .06 .808 .103 .187 .075 .17 
PQ11 .133 .095 .155 .215 .116 .778 -.063 .14 .153 .013 
PQ26 .128 .223 .067 .09 .106 .771 .067 .322 .186 .081 
 
  107 
 
Table C2: PQ Structure Matrix (continued) 
 1 2 3 4 5 6 7 8 9 10 
PQ46 .358 .265 .102 .247 -.026 .576 -.064 .558 .244 .053 
PQ17 .22 .297 .125 .186 .189 .131 .746 .062 -.088 .122 
PQ07 .419 .213 .318 .104 .167 .06 .589 .046 .231 -.083 
PQ16 .403 .007 .344 .289 .129 -.108 .502 -.086 .167 .011 
PQ44 .305 .334 .234 .305 .429 .213 -.002 .719 .366 -.103 
PQ49 .241 .289 .183 .108 .164 .198 .015 .7 .159 .112 
PQ19 .303 .282 .274 .095 .144 .128 .142 .119 .729 .016 
PQ54 .305 .103 .232 .343 .322 .245 -.057 .377 .611 .042 
PQ52 .377 .213 .306 .32 .149 .192 .102 .141 .08 .641 
PQ53 .47 .242 .414 .309 .31 .148 -.05 .072 .336 .553 
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Table D1: OQ-45.2 CFA Unstandardized Regression 
Weights 
   Estimate S.E. C.R. P 
OQ02 ¬ SD 1    
OQ03 ¬ SD 1.321 0.126 10.471 .0001 
OQ05 ¬ SD 1.293 0.122 10.564 .0001 
OQ06 ¬ SD 1.205 0.113 10.674 .0001 
OQ08 ¬ SD 1.05 0.104 10.061 .0001 
OQ09 ¬ SD 1.548 0.141 11.006 .0001 
OQ10 ¬ SD 1.534 0.143 10.76 .0001 
OQ11t ¬ SD -0.039 0.016 -2.465 .014 
OQ13 ¬ SD 1.197 0.115 10.379 .0001 
OQ15 ¬ SD 1.815 0.154 11.755 .0001 
OQ22 ¬ SD 1.174 0.115 10.166 .0001 
OQ23 ¬ SD 1.759 0.153 11.479 .0001 
OQ24 ¬ SD 1.445 0.131 11.073 .0001 
OQ25 ¬ SD 1.379 0.135 10.202 .0001 
OQ27 ¬ SD 1.108 0.123 9.025 .0001 
OQ29 ¬ SD 1.346 0.133 10.147 .0001 
OQ31 ¬ SD 1.339 0.128 10.442 .0001 
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Table D1: OQ-45.2 CFA Unstandardized Regression 
Weights (continued) 
   Estimate S.E. C.R. P 
OQ33 ¬ SD 1.453 0.138 10.542 .0001 
OQ34 ¬ SD 0.749 0.112 6.672 .0001 
OQ35 ¬ SD 0.752 0.095 7.908 .0001 
OQ36 ¬ SD 1.318 0.128 10.29 .0001 
OQ40 ¬ SD 1.781 0.16 11.12 .0001 
OQ41 ¬ SD 1.338 0.143 9.356 .0001 
OQ42 ¬ SD 1.749 0.15 11.672 .0001 
OQ45 ¬ SD 1.08 0.127 8.504 .0001 
OQ01 ¬ IR 1    
OQ07 ¬ IR 3.464 0.5 6.925 .0001 
OQ16 ¬ IR 1.837 0.316 5.822 .0001 
OQ17 ¬ IR 3 0.46 6.518 .0001 
OQ18 ¬ IR 3.926 0.537 7.314 .0001 
OQ19 ¬ IR 2.295 0.358 6.409 .0001 
OQ20 ¬ IR 3.468 0.472 7.342 .0001 
OQ26t ¬ IR -0.098 0.045 -2.18 .029 
OQ30 ¬ IR 1.507 0.259 5.827 .0001 
OQ37 ¬ IR 3.447 0.49 7.038 .0001 
OQ43 ¬ IR 2.841 0.397 7.148 .0001 
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Table D1: OQ-45.2 CFA Unstandardized Regression 
Weights (continued) 
   Estimate S.E. C.R. P 
OQ04 ¬ SR 1    
OQ12 ¬ SR 0.986 0.095 10.339 .0001 
OQ14 ¬ SR 0.048 0.08 0.592 .554 
OQ21 ¬ SR 0.973 0.095 10.247 .0001 
OQ28 ¬ SR 1.23 0.107 11.472 .0001 
OQ32t ¬ SR -0.037 0.013 -2.904 .004 
OQ38 ¬ SR 1.213 0.103 11.823 .0001 
OQ39 ¬ SR 0.745 0.08 9.314 .0001 




Table D2: Standardized Regression 
Weights 
   Estimate 
OQ02 ¬ SD .528 
OQ03 ¬ SD .657 
OQ05 ¬ SD .667 
OQ06 ¬ SD .679 
OQ08 ¬ SD .615 
OQ09 ¬ SD .716 
OQ10 ¬ SD .688 
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Table D2: Standardized Regression 
Weights (continued) 
   Estimate 
OQ11t ¬ SD -.12 
OQ13 ¬ SD .647 
OQ15 ¬ SD .814 
OQ22 ¬ SD .625 
OQ23 ¬ SD .776 
OQ24 ¬ SD .724 
OQ25 ¬ SD .629 
OQ27 ¬ SD .522 
OQ29 ¬ SD .623 
OQ31 ¬ SD .654 
OQ33 ¬ SD .664 
OQ34 ¬ SD .352 
OQ35 ¬ SD .436 
OQ36 ¬ SD .638 
OQ40 ¬ SD .73 
OQ41 ¬ SD .55 
OQ42 ¬ SD .802 
OQ45 ¬ SD .48 
OQ01 ¬ IR .361 
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Table D2: Standardized 
Regression Weights (continued) 
   Estimate 
OQ07 ¬ IR .623 
OQ16 ¬ IR .407 
OQ17 ¬ IR .523 
OQ18 ¬ IR .765 
OQ19 ¬ IR .502 
OQ20 ¬ IR .778 
OQ26t ¬ IR -.113 
OQ30 ¬ IR .408 
OQ37 ¬ IR .658 
OQ43 ¬ IR .696 
OQ04 ¬ SR .618 
OQ12 ¬ SR .585 
OQ14 ¬ SR .03 
OQ21 ¬ SR .579 
OQ28 ¬ SR .67 
OQ32t ¬ SR -.148 
OQ38 ¬ SR .698 
OQ39 ¬ SR .515 
OQ44 ¬ SR .505 
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Table D3: OQ-45.2 Subscale Covariances 
   Estimate S.E. C.R. P 
SD « SR 0.294 0.037 7.966 .0001 
SD « IR 0.101 0.017 5.876 .0001 




Table D4: OQ-45.2 
Correlations 
   Estimate 
SD « SR .857 
SD « IR .785 




Table D5: OQ-45.2 CFA Variances 
 Estimate S.E. C.R. P 
SD 0.279 0.047 5.913 .0001 
IR 0.06 0.016 3.736 .0001 
SR 0.422 0.062 6.82 .0001 
e02 0.722 0.049 14.721 .0001 
e03 0.643 0.044 14.469 .0001 
e05 0.583 0.04 14.44 .0001 
e06 0.474 0.033 14.404 .0001 
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Table D5: OQ-45.2 CFA Variances (continued) 
 Estimate S.E. C.R. P 
e08 0.506 0.035 14.571 .0001 
e09 0.633 0.044 14.267 .0001 
e10 0.729 0.051 14.372 .0001 
e11 0.029 0.002 14.973 .0001 
e13 0.555 0.038 14.495 .0001 
e15 0.468 0.034 13.649 .0001 
e22 0.598 0.041 14.548 .0001 
e23 0.571 0.041 13.956 .0001 
e24 0.527 0.037 14.233 .0001 
e25 0.811 0.056 14.539 .0001 
e27 0.916 0.062 14.73 .0001 
e29 0.796 0.055 14.552 .0001 
e31 0.671 0.046 14.477 .0001 
e33 0.746 0.052 14.448 .0001 
e34 1.102 0.074 14.887 .0001 
e35 0.674 0.045 14.824 .0001 
e36 0.707 0.049 14.518 .0001 
e40 0.774 0.055 14.207 .0001 
e41 1.153 0.078 14.689 .0001 
e42 0.473 0.034 13.757 .0001 
e45 1.087 0.074 14.78 .0001 
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Table D5: OQ-45.2 CFA Variances (continued) 
 Estimate S.E. C.R. P 
e01 0.397 0.027 14.701 .0001 
e07 1.128 0.082 13.785 .0001 
e16 1.011 0.069 14.609 .0001 
e17 1.421 0.1 14.272 .0001 
e18 0.65 0.053 12.294 .0001 
e19 0.932 0.065 14.349 .0001 
e20 0.466 0.039 12.055 .0001 
e26 0.044 0.003 14.959 .0001 
e30 0.677 0.046 14.608 .0001 
e37 0.929 0.069 13.54 .0001 
e43 0.511 0.039 13.199 .0001 
e04 0.681 0.05 13.516 .0001 
e12 0.787 0.057 13.752 .0001 
e14 1.056 0.071 14.981 .0001 
e21 0.793 0.057 13.794 .0001 
e28 0.785 0.06 13.046 .0001 
e32 0.026 0.002 14.931 .0001 
e38 0.655 0.052 12.714 .0001 
e39 0.649 0.046 14.133 .0001 
e44 0.636 0.045 14.179 .0001 
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Table E1: OQ-45.2 Pattern Matrix  
 1 2 3 4 5 6 7 8 9 
OQ24 .858 .031 -.15 -.051 -.054 .005 .089 .225 -.065 
OQ13 .834 -.044 -.022 .02 -.11 -.002 .022 .322 .048 
OQ31 .801 -.114 .036 -.066 .145 .012 .005 .048 .126 
OQ21 .709 .053 -.039 .011 .075 -.005 -.123 .143 -.016 
OQ03 .661 -.051 .015 .26 -.173 .009 .083 -.009 -.023 
OQ43 .641 .01 .054 -.021 .151 -.041 -.045 .358 .057 
OQ15 .541 .365 -.025 -.035 -.017 -.032 .201 -.019 -.066 
OQ23 .524 .353 -.01 -.128 .039 -.039 .166 -.008 -.035 
OQ20 .513 -.07 -.088 .03 .506 .026 .016 .165 .083 
OQ42 .484 .21 .04 .082 .066 -.024 .112 -.208 -.013 
OQ06 .461 -.13 .192 .183 -.094 -.067 .097 -.107 .423 
OQ10 .067 .833 .082 -.165 -.029 -.11 -.059 -.06 .002 
OQ36 .027 .737 -.05 .082 -.02 -.012 -.068 .027 .002 
OQ33 .114 .649 .137 . -.029 .014 -.094 .061 .02 
OQ35 -.138 .621 -.299 .257 -.013 -.099 .192 .173 -.055 
OQ29 -.11 .575 .238 .161 -.028 .06 -.107 .101 .059 
OQ25 .017 .566 .028 -.143 -.021 .075 .317 . .086 
OQ05 .3 .456 .112 -.137 -.031 -.038 .007 -.202 .094 
OQ38 .051 .105 .789 -.037 .033 .028 .005 .032 -.209 
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Table E1: OQ-45.2 Pattern Matrix (continued) 
 1 2 3 4 5 6 7 8 9 
OQ04 .053 -.07 .73 .052 -.081 -.05 .039 -.001 .109 
OQ39 -.249 .018 .677 -.071 .027 .014 .238 .353 .141 
OQ28 -.103 .224 .647 .195 .197 .014 -.098 -.046 -.182 
OQ22 .23 .23 .264 .247 -.047 .063 -.029 -.134 -.175 
OQ02 .315 -.223 .034 .773 -.042 .036 -.24 -.004 .006 
OQ34 -.255 .194 -.045 .671 .133 -.026 .066 .183 -.166 
OQ45 -.039 -.076 .056 .671 -.085 -.091 .057 -.039 .31 
OQ27 -.137 .285 .026 .533 .042 -.02 .011 .04 .248 
OQ09 .201 .235 -.002 .466 .041 .117 .029 -.045 -.054 
OQ17 -.118 -.088 .066 .037 .789 .005 .018 -.102 .139 
OQ07 -.067 .068 -.085 .025 .638 -.006 -.032 -.126 .483 
OQ37 .303 -.061 .043 -.05 .633 .022 -.04 .082 .013 
OQ18 .325 .292 .06 -.105 .405 -.046 -.038 -.079 .003 
OQ26 -.105 -.069 -.068 .016 .075 .849 .173 -.068 .051 
OQ32 .043 -.241 .078 .053 .061 .82 .094 -.04 -.058 
OQ11 .013 .306 -.027 -.171 -.195 .642 -.26 .15 .139 
OQ44 -.018 -.026 .281 -.143 -.035 -.019 .742 .071 .093 
OQ08 .259 -.029 -.142 .036 .036 .106 .715 -.174 -.066 
OQ40 .277 .275 -.006 .046 -.093 .036 .42 -.066 -.016 
OQ01 .455 -.102 .049 -.005 -.009 -.039 -.103 .771 -.103 
OQ30 .203 .24 .051 .154 -.127 .051 .001 .585 .151 
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Table E1: OQ-45.2 Pattern Matrix (continued) 
 1 2 3 4 5 6 7 8 9 
OQ19 .004 -.065 -.001 .058 .276 .047 .102 .103 .721 




Table E2: OQ-45.2 Structure Matrix 
 1 2 3 4 5 6 7 8 9 
OQ31 .804 .364 .338 .209 .419 .106 .212 -.051 .262 
OQ15 .755 .69 .401 .395 .291 .115 .476 -.094 .093 
OQ24 .753 .403 .237 .221 .265 .111 .312 .113 .073 
OQ13 .735 .371 .346 .271 .193 .104 .288 .207 .184 
OQ42 .728 .601 .404 .442 .322 .087 .348 -.285 .125 
OQ23 .716 .633 .359 .289 .328 .103 .414 -.077 .119 
OQ03 .695 .427 .405 .501 .09 .084 .326 -.11 .096 
OQ21 .693 .385 .259 .243 .344 .094 .122 .016 .113 
OQ43 .66 .368 .336 .213 .389 .084 .221 .258 .185 
OQ06 .619 .367 .491 .417 .092 -.005 .292 -.166 .517 
OQ18 .617 .534 .284 .214 .595 .084 .176 -.148 .13 
OQ10 .46 .773 .352 .285 .2 .05 .248 -.129 .149 
OQ36 .404 .735 .281 .41 .189 .134 .242 -.05 .118 
OQ33 .483 .725 .431 .388 .196 .167 .253 -.011 .16 
OQ25 .392 .665 .34 .257 .165 .213 .523 .023 .194 
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Table E2: OQ-45.2 Structure Matrix (continued) 
 1 2 3 4 5 6 7 8 9 
OQ29 .326 .659 .48 .468 .118 .198 .24 .057 .168 
OQ05 .576 .615 .377 .269 .205 .076 .243 -.264 .232 
OQ35 .172 .58 .064 .416 .106 .022 .385 .133 -.006 
OQ38 .411 .426 .818 .369 .125 .145 .323 .049 -.069 
OQ04 .345 .292 .764 .356 -.024 .027 .288 .017 .21 
OQ28 .392 .527 .734 .53 .266 .139 .243 -.059 -.06 
OQ39 .082 .233 .663 .181 . .117 .444 .452 .204 
OQ02 .419 .247 .328 .723 .068 .058 .008 -.137 .049 
OQ09 .537 .615 .4 .679 .232 .223 .326 -.121 .043 
OQ45 .232 .293 .341 .662 -.052 -.059 .23 -.088 .321 
OQ34 .093 .385 .225 .657 .136 .055 .281 .147 -.154 
OQ27 .285 .535 .357 .645 .124 .075 .271 -.011 .295 
OQ22 .53 .557 .53 .558 .138 .162 .27 -.197 -.051 
OQ17 .219 .148 .07 .063 .737 .064 .032 -.083 .151 
OQ37 .489 .255 .163 .087 .728 .118 .086 .041 .09 
OQ20 .638 .338 .177 .186 .683 .136 .185 .091 .177 
OQ07 .277 .256 .02 .069 .647 .056 .003 -.137 .498 
OQ26 .033 .127 .032 .038 .119 .836 .173 .041 .04 
OQ32 .109 .054 .139 .075 .114 .8 .126 .048 -.053 
OQ11 .034 .202 .029 -.086 -.067 .66 -.122 .157 .174 
OQ44 .245 .302 .467 .174 .015 .069 .79 .203 .151 
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Table E2: OQ-45.2 Structure Matrix (continued) 
 1 2 3 4 5 6 7 8 9 
OQ08 .446 .387 .219 .298 .182 .172 .726 -.106 -.007 
OQ40 .539 .596 .386 .41 .124 .15 .609 -.066 .095 
OQ01 .251 .039 .171 .025 .115 .05 .108 .697 -.037 
OQ30 .315 .406 .344 .314 .04 .177 .306 .53 .235 
OQ19 .245 .201 .164 .101 .309 .1 .166 .118 .731 
OQ16 .278 .397 -.016 .143 .193 .098 -.093 -.228 .52 
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Table F1: OQ-45.2 Validation Unstandardized 
Regression Weights 
   Estimate S.E. C.R. 
OQ24 ¬ Depression 1   
OQ03 ¬ Depression 0.946 0.071 13.319 
OQ43 ¬ Depression 0.856 0.068 12.549 
OQ15 ¬ Depression 1.201 0.078 15.313 
OQ23 ¬ Depression 1.225 0.081 15.113 
OQ20 ¬ Depression 0.885 0.071 12.546 
OQ42 ¬ Depression 1.175 0.077 15.292 
OQ13 ¬ Depression 0.796 0.064 12.518 
OQ31 ¬ Depression 1.101 0.074 14.97 
OQ21 ¬ Depression 0.872 0.077 11.361 
OQ36 ¬ Anxiety 1   
OQ33 ¬ Anxiety 0.997 0.079 12.586 
OQ29 ¬ Anxiety 0.918 0.08 11.519 
OQ05 ¬ Anxiety 0.769 0.072 10.696 
OQ10 ¬ Anxiety 1.116 0.083 13.393 
OQ35 ¬ Anxiety 0.392 0.05 7.877 
OQ25 ¬ Anxiety 1.067 0.088 12.125
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Table F1: OQ-45.2 Validation Unstandardized 
Regression Weights (continued) 
   Estimate S.E. C.R. 
OQ38 ¬ Role 1  
OQ39 ¬ Role 0.463 0.052 8.93
OQ04 ¬ Role 0.741 0.06 12.378
OQ28 ¬ Role 1.112 0.069 16.146
OQ45 ¬ Somatic 1  
OQ34 ¬ Somatic 0.883 0.104 8.489
OQ02 ¬ Somatic 0.912 0.098 9.338
OQ09 ¬ Somatic 1.308 0.117 11.215
OQ07 ¬ LoveRelat 1  
OQ17 ¬ LoveRelat 1.065 0.118 9.038
OQ37 ¬ LoveRelat 1.029 0.104 9.941
OQ18 ¬ LoveRelat 1.208 0.114 10.623
OQ32t ¬ Alcohol 1  
oQ26t ¬ Alcohol 1.394 0.092 15.133
oQ11t ¬ Alcohol 0.754 0.062 12.235
OQ08 ¬ Danger 1  
OQ40 ¬ Danger 2.149 0.196 10.975
OQ44 ¬ Danger 1.064 0.128 8.283
OQ30 ¬ Relationships 1  
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Table F1: OQ-45.2 Validation Unstandardized 
Regression Weights (continued) 
   Estimate S.E. C.R. 
OQ01 ¬ Relationships 0.573 0.088 6.511
OQ19 ¬ Conflict 1  
OQ16 ¬ Conflict 0.755 0.11 6.845
OQ27 ¬ Somatic 1.038 0.11 9.43
OQ22 ¬ Somatic 1.059 0.102 10.391




Table F2: Standardized Regression 
Weights 
   Estimate 
OQ24 ¬ Depression .698
OQ03 ¬ Depression .663
OQ43 ¬ Depression .623
OQ15 ¬ Depression .767
OQ23 ¬ Depression .756
OQ20 ¬ Depression .623
OQ42 ¬ Depression .766
OQ13 ¬ Depression .622
OQ31 ¬ Depression .749
OQ21 ¬ Depression .563
OQ36 ¬ Anxiety .672
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Table F2: Standardized Regression 
Weights (continued) 
   Estimate 
OQ33 ¬ Anxiety .675
OQ29 ¬ Anxiety .611
OQ05 ¬ Anxiety .563
OQ10 ¬ Anxiety .726
OQ35 ¬ Anxiety .406
OQ25 ¬ Anxiety .647
OQ38 ¬ Role .779
OQ39 ¬ Role .448
OQ04 ¬ Role .611
OQ28 ¬ Role .797
OQ45 ¬ Somatic .549
OQ34 ¬ Somatic .497
OQ02 ¬ Somatic .568
OQ09 ¬ Somatic .767
OQ07 ¬ LoveRelat .559
OQ17 ¬ LoveRelat .565
OQ37 ¬ LoveRelat .655
OQ18 ¬ LoveRelat .74
OQ32t ¬ Alcohol .815
OQ26t ¬ Alcohol .933
OQ11t ¬ Alcohol .567
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Table F2: Standardized Regression 
Weights (continued) 
   Estimate 
OQ08 ¬ Danger .536
OQ40 ¬ Danger .804
OQ44 ¬ Danger .496
OQ30 ¬ Relationships .684
OQ01 ¬ Relationships .467
OQ19 ¬ Conflict .594
OQ16 ¬ Conflict .402
OQ27 ¬ Somatic .576
OQ22 ¬ Somatic .67




Table F3: OQ-45.2 Validation Subscale Covariances 
   Estimate S.E. C.R. P 
Relationships « Conflict 0.18 0.03 5.279 .0001 
Danger « Relationships 0.169 0.03 6.306 .0001 
Alcohol « Danger -0.003 0 -0.91 .361 
LoveRelat « Alcohol -0.008 0.01 -1.39 .164 
Somatic « LoveRelat 0.218 0.04 5.606 .0001 
Role « Somatic 0.435 0.05 8.279 .0001 
Anxiety « Role 0.43 0.05 8.615 .0001 
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Table F3: OQ-45.2 Validation Subscale Covariances (continued) 
   Estimate S.E. C.R. P 
Depression « Anxiety 0.395 0.04 8.917 .0001 
Danger « Conflict 0.186 0.03 6.406 .0001 
Alcohol « Conflict 0.002 0.01 0.474 .636 
LoveRelat « Conflict 0.327 0.05 6.813 .0001 
Somatic « Conflict 0.288 0.04 7.002 .0001 
Role « Conflict 0.258 0.04 6.097 .0001 
Anxiety « Conflict 0.307 0.04 7.332 .0001 
Depression « Conflict 0.313 0.04 7.722 .0001 
Alcohol « Relationships -0.006 0.01 -1.18 .238 
LoveRelat « Relationships 0.217 0.04 5.506 .0001 
Somatic « Relationships 0.151 0.03 4.848 .0001 
Role « Relationships 0.291 0.04 6.899 .0001 
Anxiety « Relationships 0.158 0.03 4.708 .0001 
Depression « Relationships 0.256 0.04 7.295 .0001 
LoveRelat « Danger 0.17 0.03 5.63 .0001 
Somatic « Danger 0.236 0.03 7.113 .0001 
Role « Danger 0.3 0.04 7.842 .0001 
Anxiety « Danger 0.297 0.04 7.984 .0001 
Depression « Danger 0.277 0.03 8.065 .0001 
Somatic « Alcohol -0.004 0.01 -0.91 .362 
Role « Alcohol -0.01 0.01 -1.53 .127 
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Table F3: OQ-45.2 Validation Subscale Covariances (continued) 
   Estimate S.E. C.R. P 
Anxiety « Alcohol -0.01 0.01 -1.92 .055 
Depression « Alcohol -0.005 0.01 -1.07 .283 
Role « LoveRelat 0.258 0.05 5.516 .0001 
Anxiety « LoveRelat 0.284 0.04 6.429 .0001 
Depression « LoveRelat 0.429 0.05 8.116 .0001 
Anxiety « Somatic 0.392 0.05 8.104 .0001 
Depression « Somatic 0.347 0.04 8.039 .0001 




Table F4: OQ-45.2 Validation Correlations 
   Estimate 
Relationships « Conflict .485 
Danger « Relationships .603 
Alcohol « Danger -.054 
LoveRelat « Alcohol -.081 
Somatic « LoveRelat .445 
Role « Somatic .777 
Anxiety « Role .674 
Depression « Anxiety .742 
Danger « Conflict .633 
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Table F4: OQ-45.2 Validation Correlations 
(continued) 
   Estimate 
Alcohol « Conflict .03 
LoveRelat « Conflict .696 
Somatic « Conflict .717 
ROle « Conflict .478 
Anxiety « Conflict .669 
Depression « Conflict .696 
Alcohol « Relationships -.08 
LoveRelat « Relationships .482 
Somatic « Relationships .393 
Role « Relationships .565 
Anxiety « Relationships .359 
Depression « Relationships .596 
LoveRelat « Danger .477 
Somatic « Danger .773 
Role « Danger .735 
Anxiety « Danger .853 
Depression « Danger .813 
Somatic « Alcohol -.051 
Role « Alcohol -.085 
Anxiety « Alcohol -.106 
Depression « Alcohol -.056 
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Table F4: OQ-45.2 Validation Correlations 
(continued) 
   Estimate 
Role « LoveRelat .393 
Anxiety « LoveRelat .509 
Depression « LoveRelat .786 
Anxiety « Somatic .823 





Table F5: OQ-45.2 Validation Variances 
 Estimate S.E. C.R. P 
Depression 0.521 0.06 8.267 .0001 
Anxiety 0.543 0.07 7.644 .0001 
Role 0.75 0.08 9.127 .0001 
Somatic 0.417 0.07 5.928 .0001 
LoveRelat 0.572 0.1 5.862 .0001 
Alcohol 0.017 0 9.114 .0001 
Danger 0.223 0.04 5.695 .0001 
Relationships 0.354 0.07 5.217 .0001 
Conflict 0.387 0.07 5.975 .0001 
e02 0.729 0.05 13.93 .0001 
e03 0.595 0.04 14.08 .0001 
Depression « Role .683 
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Table F5: OQ-45.2 Validation Variances 
(continued) 
 Estimate S.E. C.R. P 
e05 0.694 0.05 14.02 .0001 
e06 0.431 0.04 9.951 .0001 
e08 0.552 0.04 13.93 .0001 
e09 0.5 0.04 11.67 .0001 
e10 0.606 0.05 12.63 .0001 
e11 0.02 0 13.91 .0001 
e15 0.527 0.04 13.33 .0001 
e22 0.574 0.04 13.16 .0001 
e23 0.586 0.04 13.44 .0001 
e24 0.548 0.04 13.89 .0001 
e25 0.859 0.06 13.48 .0001 
e27 0.905 0.07 13.89 .0001 
e29 0.768 0.06 13.75 .0001 
e31 0.495 0.04 13.51 .0001 
e33 0.643 0.05 13.23 .0001 
e34 0.991 0.07 14.27 .0001 
e35 0.423 0.03 14.58 .0001 
e36 0.661 0.05 13.27 .0001 
e40 0.562 0.07 8.483 .0001 
e42 0.508 0.04 13.34 .0001 
e45 0.968 0.07 14.04 .0001 
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Table F5: OQ-45.2 Validation Variances 
(continued) 
 Estimate S.E. C.R. P 
e01 0.418 0.03 12.73 .0001 
e07 1.256 0.09 13.47 .0001 
e18 0.69 0.06 10.79 .0001 
e19 0.709 0.06 12.29 .0001 
e20 0.642 0.05 14.25 .0001 
e26 0.005 0 2.651 .008 
e30 0.403 0.06 6.807 .0001 
e37 0.806 0.07 12.45 .0001 
e43 0.601 0.04 14.25 .0001 
e04 0.691 0.05 13.39 .0001 
e21 0.854 0.06 14.45 .0001 
e28 0.534 0.05 10.18 .0001 
e32 0.009 0 7.789 .0001 
e39 0.643 0.05 14.32 .0001 
e44 0.771 0.06 14.14 .0001 
e17 1.383 0.1 13.43 .0001 
e38 0.486 0.05 10.72 .0001 
e13 0.524 0.04 14.26 .0001 
e16 1.143 0.08 14.09 .0001 
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